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ABSTRACT OF THE DISSERTATION 
VITAMIN D LEVELS, VITAMIN D RECEPTOR POLYMORPHISMS AND HOMA2 
MODEL IN CUBAN AMERICANS, HAITIAN AMERICANS, AND AFRICAN 
AMERICANS WITH AND WITHOUT TYPE 2 DIABETES. 
by 
Lamya H. Shaban 
Florida International University, 2012 
Miami, Florida 
Professor Fatma G. Huffman, Major Professor 
This cross sectional study investigated the association between 25-
hydroxyvitamin D (25(OH)D) levels, vitamin D receptor (VDR) polymorphisms, 
HOMA2 and diabetes status in Cuban Americans, Haitian Americans, and African 
Americans. The sample for the study included a total of 885 participants (Cuban 
American = 370; Haitian American = 259; African American = 256). Serum 25(OH)D 
levels were determined using a commercial ELISA kit from Immunodiagnostic Systems 
Limited. Polymerase chain reaction-restriction fragment length polymorphism (PCR- 
RFLP) was used for genotyping BsmI and TaqI, Real-time- Polymerase chain reaction 
(RT-PCR) was used for ApaI. HOMA2 model calculations were used as a surrogate 
marker for insulin resistance, insulin sensitivity and β-cell function. All statistical 
analyses were performed using SPSS (Version 18.0, Chicago, IL, U.S.). Student’s t-test 
and analysis of variance (ANOVA), χ2 test and logistic regression analysis were used. 
We found that Cuban Americans without T2D had significantly lower odds of having 
insufficient 25(OH)D compared to all other groups. Participants with darker skin (Haitian 
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Americans and African Americans) and those with T2D had the greatest risk of having 
insufficient levels of 25(OH)D. Cuban Americans with T2D had a protective factor for 
vitamin D insufficiency if they carried the TaqI genotype (tt) (p < 0.02) and Cuban 
Americans without T2D had the highest β-cell function levels (p < 0.05).  
Further investigation is needed to have a better understanding of the role vitamin 
D, VDR polymorphisms and the role HOMA2 model plays in the three ethnicities. 
Awareness of the high prevalence of vitamin D insufficiency among Haitian Americans 
and African Americans and also in those with T2D may sensitize physicians and 
dietitians to increase efforts to prevent vitamin D insufficiency. Further research to 
investigate the role and mechanism of action of vitamin D and diabetes is warranted.
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I. INTRODUCTION 
 Type 2 diabetes (T2D) accounts for about 90 to 95 percent of all diagnosed cases of 
diabetes (ADA, 2011). The physiology of the disease begins with insulin resistance 
where the cells of the body become resistant and do not use insulin properly. In turn the 
body produces greater amounts of insulin and as the need for insulin rises, the pancreas 
gradually loses its ability to produce insulin in sufficient quantities (NIDDK, 2008). Type 
2 diabetes is associated with older age, obesity, family history of diabetes, history of 
gestational diabetes, impaired glucose metabolism, physical inactivity, and race/ethnicity 
(NIDDK, 2008). African Americans, Hispanic/Latino Americans, American Indians, and 
some Asian Americans and Native Hawaiians or other Pacific Islanders have been 
reported to be at high risk for type 2 diabetes and its complications (NIDDK, 2008). In 
addition to other lifestyle factors, there is a growing interest in the association between 
ethnicity, T2D and vitamin D, in particular, vitamin D insufficiency and Vitamin D 
Receptor (VDR) polymorphisms.  
Vitamin D deficiency and its relationship to impaired glucose tolerance along with 
the discovery of receptors of 1, 25-dihydroxyvitamin D3 (the active form of vitamin D) 
have created interest in the potential role of vitamin D in the pathogenesis of the disease 
(Mathieu, Gysemans, Bouillon, & Bouillon, 2005). Since the early 1980s it has been 
reported that vitamin D deficiency inhibits pancreatic secretion and turnover of insulin, 
leading to impaired glucose metabolism (Mathieu et al., 2005). It was thought that 
vitamin D deficiency in fact hinders insulin secretion (Boucher, 1998; Norman, Frankel, 
Heldt, & Grodsky, 1980) through β- cell dysfunction (Chiu, Chu, Go, & Saad, 2004) and 
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modulates lipolysis (Dirirnzo, & Zemel, 2000; Rammos, Tseke, & Ziakka, 2008; Zemel, 
Shi, Greer).  
Although it is not exactly clear how the pathogenesis of hypovitaminosis D could 
affect glucose/insulin metabolism, a number of studies indicated an association of low 
serum vitamin D levels with high serum glucose and insulin resistance (Choi, 2011; 
Gannagé-Yared, 2009; Reis, 2009). However, there is no documented evidence to date 
regarding vitamin D, T2D and clinical outcomes comparing ethnic groups such as Cuban 
Americans, Haitian Americans, and African Americans. Along with the relationship of 
vitamin D with insulin secretion, the vitamin D receptor (VDR) gene may also play a role 
in T2D, insulin secretion and insulin resistance. VDR polymorphisms, vitamin D and 
their association with T2D is a novel field of research. The interaction between the 
genetic variations between different ethnicities, i.e., Cuban Americans, Haitian 
Americans, and African Americans and the role vitamin D plays in T2D has not been 
explored.  
The proposed study is an ancillary study that will use existing blood samples, 
dietary and other data from the parent study to generate new data on understudied ethnic 
groups (Cuban Americans, Haitian Americans, and African Americans). Blood samples 
will be used to generate data in order to assess the association between vitamin D status, 
diabetes status, vitamin D receptor polymorphisms and the HOMA2 model.  
The proposed project will consist of three chapters; each chapter will address specific 
aims and hypotheses. 
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Specific aims and hypotheses:  
 
CHAPTER III. SERUM VITAMIN D INSUFFICIENCY AND DIABETES     
                           STATUS IN THREE ETHNIC GROUPS 
 
Specific Aim 1: To determine the association between vitamin D status and diabetes 
status in Cuban Americans, Haitian Americans, and African Americans.  
 
Hypothesis 1a: Cuban American, Haitian American, and African American participants 
with T2D will have lower serum vitamin D levels than their counterparts without T2D. 
• Vitamin D status was measured through serum 25(OH)D using a sandwich based 
Enzyme-Linked ImmunoSorbant Assay (ELISA kit). Glycemic control was 
determined by measuring A1c with a monoclonal method. Existing research has 
found that persons with adult-onset diabetes have low levels of vitamin D compared 
to their counterparts without diabetes (Cavalier, 2011; Isaia, Giorgini, & Adami, 
2001; Pilz, 2011; Scragg et al., 1995).  
Hypothesis 1b: Haitian American and African American participants will have lower 
serum vitamin D levels as compared to their Cuban American counterparts in both 
participants with and without T2D. 
• Serum Vitamin D status was measured as in Hypothesis 1a. Due to the fairer skin of 
the Cuban Americans it was assumed that they will have more efficient conversion of 
vitamin D by UVB rays (duration of sun exposure was not measured).  
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Hypothesis 1c: Cuban Americans, Haitian Americans, and African Americans with 
adequate (> 400 IU/day) vitamin D intake will have ‘sufficient’ (≥75nmol/L) serum 
vitamin D levels regardless of diabetes status. 
• Vitamin D intake was measured through a semi-quantitative food frequency 
questionnaire developed by Walter C. Willett (Willett, Sampson, & Stampfer, 1985). 
Hypothesis 1a outlines serum Vitamin D measurements. 
 
Chapter IV. VITAMIN D RECEPTOR POLYMORPHISMS, VITAMIN D   
                       LEVELS, AND DIABETES  STATUS IN THREE ETHNIC 
                       GROUPS 
 
Specific Aim 1: To determine the association of vitamin D receptor (VDR) 
polymorphisms (BsmI, TaqI and ApaI), and diabetes status in Cuban Americans, Haitian 
Americans, and African Americans. 
 
Hypothesis 1a: There will be a higher prevalence of polymorphisms in the VDR gene 
restriction sites BsmI, TaqI and ApaI for participants with T2D as compared to 
participants without T2D for all ethnicities.  
• VDR polymorphisms will be determined using restriction enzymes BsmI, TaqI and 
ApaI. Several studies indicate that polymorphisms are present in individuals with 
T2D (Bid, Konwar, & Aggarwal, 2009; Malecki, Frey, & Moczulski, 2003; Ye, Reis, 
& Dubois-Laforgue, 2001), however no ethnic differences have been studied. 
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Hypothesis 1b: There will be differences in the prevalence and types of VDR 
polymorphisms among the three ethnicities in participants with and without T2D.  
• Hypothesis 1a details methodology for VDR polymorphism determinations.  
 
CHAPTER V. HOMA2 MODEL, VITAMIN D LEVELS AND DIABETES  
                         STATUS IN THREE ETHNIC GROUPS 
 
Specific Aim 1: To determine the association between HOMA2 model, vitamin D, and 
diabetes status in Cuban Americans, Haitian Americans, and African Americans.  
 
Hypothesis 1a:  Insulin resistance (HOMA2) will be negatively associated with serum 
vitamin D levels for participants with and without T2D for all ethnicities.  
• Insulin secretion will be measured using an ELISA kit. Homeostasis model 
assessment (HOMA2) score will be calculated using insulin secretion and fasting 
plasma glucose. HOMA2 is a method used to assess β-cell function, insulin resistance 
and insulin sensitivity. Vitamin D levels will be measured through serum 25(OH)D. 
Hypothesis 1b:  β-cell function will be positively associated with serum vitamin D levels 
for participants with and without T2D for all ethnicities.  
• β-cell function will be calculated using insulin secretion and fasting plasma glucose. 
Vitamin D status will be measured through serum 25(OH)D using a sandwich based 
Enzyme-Linked ImmunoSorbant Assay (ELISA kit). 
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Additional Hypotheses tested: 
 
Hypothesis 1a: Cuban Americans, Haitian Americans, and African Americans with each 
polymorphism (BsmI, TaqI and ApaI) will have greater insulin resistance than those 
without VDR polymorphisms regardless of diabetes status and ethnicity. 
• Insulin resistance will be calculated using the HOMA2 model through the use of the 
insulin secretion and fasting plasma glucose.  
Hypothesis 1b: Cuban Americans, Haitian Americans, and African Americans with each 
polymorphism (BsmI, TaqI and ApaI) and ‘insufficient’ serum vitamin D levels (less than 
75nmol/L) will have lower insulin secretion than those with adequate serum vitamin D 
levels regardless of diabetes status. 
• Serum vitamin D levels will be assessed using a commercial ELISA kit and insulin 
secretion will be measured using a sandwich ELISA assay. It has been indicated that 
vitamin D and its receptor complex may play a role in β- cell insulin secretion.  
Hypothesis 1c: Cuban Americans, Haitian Americans, and African Americans with T2D 
and VDR polymorphisms (BsmI, TaqI and ApaI) will have lower insulin secretion than 
those without polymorphisms.  
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II. REVIEW OF LITERATURE 
According to the National Center for Chronic Disease Prevention and Health 
Promotion (CDC) age adjusted data indicated that minority populations are 
disproportionately affected by diabetes, with Black males and females having the highest 
percent of diabetes in 2004, with Hispanics closely behind them. Although the rate of 
diabetes has increased generally in all ethnic groups from 1980 through 2005, the age-
adjusted prevalence of diagnosed diabetes doubled among Black males and increased by 
69% among Black females. However, of all groups observed, Black females had the 
highest overall prevalence (CDC, 2009). 
Based on the National Health and Nutrition Examination Survey I (NHANES I) 
and its four follow-up surveys, adults with diabetes had a significantly higher risk of 
death, lower survival, and a lower quality of life compared with adults without diabetes 
(Gu, Cowie, & Harris, 1998). Most of these deaths were due to diabetes itself or its 
accompanying complications. The four leading causes of death among persons with T2D 
were: a) Cardiovascular disease (CVD) (~50%); b) diabetes itself (13%); c) malignant 
neoplasm (13%); and d) stroke (10%) (Harris, 1995). Less than half of the people  
(~ 45%) with T2D have adequate glycemic control (A1c levels of less than 7% which is 
the goal for persons with diabetes). Non-Hispanic Black women, Mexican American and 
African American men, ranked disproportionately higher for poor glycemic control (A1c 
less than 8%) (Harris, 1995). 
According to U.S. death certificates in 2006 diabetes was the seventh leading 
cause of death (NIDDK, 2008). More recently, age-adjusted 2004-2006 national survey 
data showed that 3.7 million African Americans had T2D; 14.7 percent of all non-
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Hispanic Blacks aged twenty and older had diagnosed and undiagnosed diabetes and 11.8 
percent had diagnosed diabetes (CDC, 2008). After adjusting for age differences, the 
2007–2009 national survey data for people aged 20 years or older indicated that 7.1% of 
non-Hispanic Whites, 11.8% of Hispanics (7.6% for Cubans) and 12.6% of non-Hispanic 
Blacks had diagnosed diabetes. Compared to White adults, the risk of diagnosed diabetes 
was 66% higher among Hispanics, and 77% higher among non-Hispanic Blacks (CDC, 
2011). 
There is limited information and statistics for African Americans, Haitian 
Americans and Cuban Americans as separate minority sub- groups with regard to 
diabetes. The existing few findings on African Americans and Hispanics; however, 
reflect the need to assess underlying factors for this increase and possible triggers or 
ethnic differences that may be a promoting factor. 
 
Sources of vitamin D 
    Vitamin D refers to the secosterols; specifically, ergocalciferol (vitamin D2) and 
cholecalciferol (vitamin D3). Vitamin D2 is ingested through commercial irradiation of 
plant sterols (ergosterol). Vitamin D3 can either be formed: endogenously by the skin 
after sun exposure (UVB solar wavelengths 290-320 nm) or through consumption of food 
of animal origin (Mathieu et al., 2005; Webb, Pilbeam, Hanafin, & Holick, 1990). The 
few dietary sources of vitamin D are somewhat limited and restricted to foods of animal 
origin such as fatty fish; cod liver oil (400 IU /tsp; and egg yolks (approx 20 IU) (Holick, 
2002; Holick, 2006). Solar UVB wavelength irradiation is the primary source of vitamin 
D for most people (other than through dietary supplementation) (Holick, 2002, 2004a, 
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2004b); however, some factors such as race; ethnicity; and age play a role in the amount 
of UVB waves that can enter into the skin and the rate at which vitamin D can be 
synthesized. Because of the limited amount of sunlight exposure and different skin 
pigmentation (dark and light- skinned) the synthesis of vitamin D from sun exposure 
tends to be inadequate and does not meet requirements of circulating 25-hydroxyvitamin 
D3 (25(OH)D) concentrations of 50-150nm/L. Most advantageous serum concentrations 
of 25(OH)D begin at 75 nmol/L (30 ng/mL) (Bischoff-Ferrari et al., 2006). Therefore, 
some countries such as the United States have fortified foods in an attempt to increase 
vitamin D levels. Foods such as milk (100 IU/8oz); some cereals (100 IU/serving); some 
yogurts (100 IU/serving); orange juice (100 IU/8oz); and margarine have been fortified. 
The estimated average requirement of vitamin D per day should be greater than 400 
IU/day or greater than 10 μg per day (IOM, 2010). Persons on special diets such as those 
on macrobiotic diets (Fitzpatrick et al. 2000), vegetarians (Kaper et al., 2000), strict 
vegans (Dunn-Emke et al., 2005) and those consuming unfortified milk alternatives such 
as soy and almond milk may be at greater risk of vitamin D deficiency if not exposed to 
adequate UVB rays (Carvalho, 2001). Recommended dietary allowance of vitamin D 
have been defined by the Institute of Medicine (IOM) as 600 IU/day for those between 
the ages of 1-70 (including pregnancy and lactation), and 800 IU/day in those over 70. 
The upper tolerable level has been defined as 1,000 IU for infants 0-6 months, 1,500 IU 
for infants 6-12 months, 2,500 IU for children 1-3 years, 3,000 IU for 4-8 years and 4,000 
IU for anyone older than eight years of age. This upper limit represents a safe upper 
boundary of the scale, however IOM stresses it is not what one should strive to consume 
(IOM, 2010).  
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Synthesis and metabolism of vitamin D 
After vitamin D is obtained from sun exposure, food, and dietary supplements it is 
biologically inert and must undergo two hydroxylations in the body for activation. The 
first occurs in the liver where vitamin D is converted into 25-hydroxyvitamin D (25(OH) 
D), also known as calcidiol. The second hydroxylation occurs primarily in the kidneys 
where it is enzymatically converted to the physiologically active 1,25-dihydroxyvitamin 
D (calcitriol) (Figure 1). Although serum 1,25-dihydroxyvitamin D (1,25(OH)2D) is the 
biologically active hormone form of vitamin D, the serum 25(OH)D is the most reliable 
indicator (in individuals without kidney disease) of vitamin D status, because it has a 
longer biological half-life than 1,25(OH)2D, and circulates in much higher 
concentrations. Serum 25(OH)D reflects the total production of vitamin D from both 
endogenous and exogenous sources such as exposure to UVB radiation and intake of 
vitamin D from different dietary forms (Wang, 2008). 
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Figure 1. Vitamin D3 synthesis, activation, and catabolism.  
Metabolism of vitamin D. Synthesis of vitamin D3 occurs in the skin where 7-
dehydrocholesterol is converted to pre- vitamin D in response to UVB exposure. Vitamin 
D3 is obtained from pre-vitamin D3 in the skin or by intestinal absorption of dietary 
components and binds to vitamin D-binding protein in the circulation where it is 
transported to the liver. Vitamin D3 is then hydroxylated by liver 25-hydroxylase 
(CYP2R1) into 25 (OH)D3. 25(OH)D3 is then hydroxylated in the kidney by 1-α-
hydroxylase (CYP27B1), generating the active hormone form 1,25(OH)2D. 
12 
 
Vitamin D function is best known for its role in the regulation of calcium homeostasis in 
the body. Additionally, through the reduction of urinary calcium loss and promoting 
calcium absorption from food in the gut, vitamin D exerts important functions in skeletal 
development and normal mineralization of bone (Holick, 2003). Without sufficient 
vitamin D bones can become thin, brittle, or misshapen. Vitamin D sufficiency prevents 
rickets in children (Mughal, 2011) and osteomalacia in adults (Lips, 2011; Nagata, 2011). 
It also plays a vital role in the prevention of osteoporosis in adults. More recently, 
literature has indicated that vitamin D not only plays a role in calcium homeostasis but 
other important metabolic actions such as its role in cell proliferation and the immune 
system (Christakos et al., 2007), involvement in the inhibition of carcinogenesis (Drake 
& Ng, 2010) and an important role in reduction in the onset of other inflammatory 
diseases such cardiovascular diseases and T2D (Anagnostis, Athyros, Adamidou, 
Florentin, & Karagiannis, 2010; Roth, 2007). 
  Recently, vitamin D status has been found to play an important role on β-cell 
function, insulin resistance, insulin sensitivity and hence the development of T2D. 
Although vitamin D function is best known for calcium homeostasis it is believed to play 
a role in β-cell function, which may be mediated by the binding of circulating 1, 25-
dihydroxyvitamin D to the vitamin D receptor in the β-cells. Alternatively, vitamin D 
could function through activation of 25(OH)D by 1-alpha-hydroxylase, which has been 
shown to be expressed in β-cells (Peechakara & Pittas, 2008). Vitamin D may also exert 
its effects by regulation of the extracellular calcium levels and calcium influx through the 
β-cells, therefore promoting insulin secretion, which is a calcium-dependent process 
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(Sheshadri, 2011). Any changes in calcium flux may negatively effects β-cell secretory 
function (Palomer, Gonzalez, Blanco-Vaca, & Mauricio, 2008; Pittas et al., 2006). 
 
Mechanism of vitamin D action 
 Mechanism of action of vitamin D in the active form 1,25(OH)2D is mediated by 
binding to the Vitamin D receptor (VDR), where 1,25(OH)2D can then exert its actions 
on target tissue (Palomer et al., 2008). VDR functions as a ligand-dependent transcription 
factor for many genes that can bind to a number of vitamin D metabolites. VDR belongs 
to the super family of nuclear receptors that include steroid, thyroid and retinoic acid 
receptors (Baker et al., 1988). Before VDR can exert its effects on the cell it must first 
form a heterodimer with retinoid X receptor (RXR) (Hibler, 2010) (Figure 2). These 
dimers may inhibit or stimulate transcription of target genes though their binding to co-
regulators, which may be stimulatory (co-activators) or inhibitory (co-suppressors). 
Different tissues in the body may have different amount of co-regulators, which indicates 
to some extent, tissue specificity for the actions of 1,25(OH)2D (Bikle, 2010). 
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Figure 2. Transcriptional control of gene expression by 1,25(OH)2D3. The diagram 
shows the key steps involved in transcriptional regulation of 1,25(OH)2D3: (1) Ligand 
binding to the vitamin D receptor (VDR); (2) heterodimerization of VDR with retinoid X 
receptor (RXR); (3) binding of the VDR/RXR complex to the vitamin D response 
element; and (4) recruitment of components of the RNA polymerase II (Pol II) complex, 
including direct interactions with captivators (CoA) and transcriptional factor IIB (B). 
Modified from Brown, A.J. (1999). Therapeutically active vitamin D analogs. 
Nephrology Exchange, 8, 14–19. 
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Vitamin D, insulin secretion, sensitivity and resistance  
Studies have shown that administration of vitamin D in both humans (Gedik & 
Akahn, 1986) and vitamin D deficient animals (Cade & Norman, 1986) improves insulin 
release and glucose tolerance (Mitri, Dawson-Hughes, Hu, & Pittas, 2011; Teegarden & 
Donkin, 2009). A review of the empirical literature that has attempted to evaluate the role 
of vitamin D in insulin secretion, sensitivity and resistance demonstrates some positive 
associations (Soares, Ping-Delfos, & She, 2008). For instance, Kayaniyil et al. (2010) 
measured levels of vitamin D, β- cell function and insulin resistance in 712 patients at-
risk for the development of T2D. The research indicated that concentrations of vitamin D 
were associated with both β- cell function and insulin resistance. Based on these findings, 
Kayaniyil et al. (2010) argue that vitamin D may play some role in the development of 
T2D. 
Nagpal, Pande and Bhartia (2009) also looked at the relationship between vitamin 
D and insulin sensitivity. The authors studied middle-aged males with central obesity that 
had not developed diabetes. Subjects were randomized to a vitamin D supplement group 
(provided once every two weeks) or a placebo group. Hepatic fasting insulin sensitivity, 
postprandial insulin sensitivity, lipid profile and blood pressure were measured at 
baseline and at the conclusion of the study (six weeks). The results of the investigation 
indicated that vitamin D improved postprandial insulin sensitivity in non-obese males 
that had not developed diabetes.  
Mitri et al. (2011) have also considered the role of vitamin D on insulin sensitivity 
and β- cell function in individuals at-risk for the development of diabetes. The research 
conducted employed a randomized, 2 x 2 factorial design with subjects receiving 
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cholecalciferol (2000 IU once daily) or calcium carbonate (400 mg twice daily) for a 
period of 16 weeks. Pancreatic β- cell function was measured following an intravenous 
glucose tolerance test. Patients receiving calcium plus vitamin D did not have improved 
outcomes when compared with those receiving vitamin D alone. Overall, subjects had 
improved β- cell function; however no statistically significant improvements in A1c 
(glycated hemoglobin) attenuation were noted. Finally, Chiu et al. (2004) found that with 
the increase in 25(OH)D intake, insulin sensitivity was also increased. In addition, with 
low levels of vitamin D, β- cell function had decreased. 
There is ample evidence indicating that vitamin D can impact insulin secretion, 
sensitivity and response. Some data also exist which provide further insight into possible 
associations between vitamin D and insulin response. Al-Sultan, Amin, Abou-Seif, and 
Al Naboli (2011) examined insulin sensitivity and β- cell function and their relation to 
vitamin D levels in obese and non-obese Saudis. While the results indicated that there 
were independent relationships between β- cell function and insulin sensitivity between 
the groups, when confounding variables such as smoking or physical activity were taken 
into consideration there were no differences in insulin sensitivity and β- cell function and 
their relationship to vitamin D levels between obese and non- obese Saudi men. Further, 
Alvarez, et al. (2010) found that vitamin D intake is associated with improved insulin 
sensitivity in African American, but not European women.  
In Arab Americans 25(OH)D levels were assessed with regards to insulin 
resistance, metabolic syndrome, and glucose intolerance. Findings indicated that vitamin 
D insufficiency and deficiency is prevalent amongst this ethnic minority and lower 
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25(OH)D in men was associated with insulin resistance, components of the metabolic 
syndrome, and glucose intolerance. Lower 25(OH)D in women was associated with CVD 
risk factors (Pinelli, Jaber, Brown, & Herman, 2010). In 5787 Korean adults low 
25(OH)D levels were associated with a high risk of T2D and findings were inversely 
associated with insulin resistance when subjects were overweight or obese (Choi, 2011). 
In contrast, Del Gobbo, Song, Dannenbaum, Dewailly, & Egeland (2011) found that 
serum 25(OH)D was not related to β -cell function or insulin resistance in 510 aboriginal 
Canadians with high risk of developing T2D. Given the scope of this data, further 
research is necessary to further understand the association between vitamin D and insulin 
action, in addition, ethnicity may play a critical role in the varied outcomes. 
 
Vitamin D and type 2 diabetes 
Longitudinal/Cohort Studies 
Efforts to evaluate the role of vitamin D in the development of T2D have focused 
on broader epidemiological evaluations (e.g., longitudinal and cohort studies) to 
determine if vitamin D plays some causal role in the development of the disease (Jorde, 
Sneve, Hutchinson, Emaus, Figenschau, & Grimes, 2010). Grimnes et al. (2010) found 
after a 10-year follow up trial of those without T2D there was an inverse association 
between 25(OH)D and development of T2D. This association however was lost after 
controlling for body mass index. 
Kirii, et al. (2009) utilized a cohort study of healthy subjects in Japan that did not 
have diabetes. These subjects were evaluated five years after initiation of the study to 
assess the number of individuals that had developed diabetes and their vitamin D intake. 
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The results indicated that there was no correlation between vitamin D intake and the 
development of T2D. Pittas, et al. (2006) through the Nurses Health Study followed 
83,779 women who had no history of diabetes but had cardiovascular disease or cancer. 
Follow-up data assessed the development of T2D at 2-4 years of the study. Dietary 
vitamin D intake was not statistically significant, and there was no correlation between 
developing T2D and vitamin D intake. However, when participants consumed vitamin D 
combined with calcium, which was assessed through a food frequency questionnaire, 
there was a 33% reduction in risk of T2D. 
Two cohort Finnish groups were studied by Laaksonen et al. (2010) between 
1978-1980 and 2000-2001. They comprehensively evaluated lifestyle factors and their 
implications for the development of T2D. In this study, five modifiable lifestyle factors 
were used to define low risk lifestyle level: BMI less than 25, occasional or regular 
exercise (approximately 30 minutes or more per day), no smoking, limited alcohol 
consumption (1–99 g/week in women and 1–199 g/week in men), and vitamin D 
consumption above the median, with serum vitamin D levels above 39 nmol/L in the first 
cohort (1978-1980) and above 44 nmol/L in the second cohort (2000-2001). Analysis of 
cohort data over a 10-year follow-up period indicated that 82 percent of T2D cases 
developed during the study could be attributed to poor lifestyle factors including vitamin 
D deficiency. Even though the authors were not able to identify the role of vitamin D and 
its role in the development of T2D, the research indicated that Vitamin D is vital to a 
healthy lifestyle and the prevention of T2D. 
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Randomized controlled/Cross-sectional studies 
Studies undertaken to evaluate vitamin D and its role in T2D have focused on 
cross sectional and randomized control studies to evaluate the impact of vitamin D 
supplementation for patients with diabetes (Jorde & Figenschau, 2009) and their 
prevalence. For instance, Witham, Dove, Dryburgh, Sugden, Morris and Struthers (2010) 
examined the use of different vitamin D doses on vascular markers for patients with T2D. 
The results of the investigation demonstrate that while reductions in systolic blood 
pressure and natriuretic peptide levels were noted, no statistically significant 
improvements in insulin resistance or A1c were found. 
Sabherwal, Bravis, & Devendra (2010) reported conflicting data who performed a 
similar study using South Asian patients with T2D. In this research, the authors found 
that vitamin D supplementation decreased both A1c levels and weight. Data collected for 
this investigation was obtained from retrospective chart analysis of patients that had and 
had not received vitamin D and calcium supplementation. Sabherwal et al. (2010) found 
that while vitamin D was important in reducing A1c and weight, the moderating role of 
calcium in these processes must also be reviewed. Based on the available data, the 
authors were not able to separate out the specific role of vitamin D in reducing A1c. 
Research undertaken by Sugden, Davies, Witham, Morris and Struthers (2008) 
further demonstrated the role that vitamin D may play in the progression of T2D. 
Specifically, these authors evaluated the use of a single high dose of vitamin D to 
improve endothelial function in patients with T2D in a double-blind randomized trial. 
The results of the investigation demonstrated that high doses of vitamin D intake during 
the winter months may improve endothelial function in patients with T2D. Improving 
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endothelial function is viewed as essential to preventing the development of 
cardiovascular disease associated with T2D. Scragg, Sowers and Bell (2004) performed 
data analysis from the Third National Health and Nutrition Examination Survey 
(NHANES) with data collected between 1998-1994. They found an inverse association 
between 25(OH)D and diabetes (associated with insulin resistance) in Mexican 
Americans and Whites adjusting for sex, age, BMI, leisure activity and quartiles of the 
year. These results were not found in Blacks. 
 
Vitamin D and sun exposure in the Sunshine State  
Melanin and sun exposure play a role in vitamin D formation and persons with 
diabetes are at a significant risk for vitamin D insufficiency. African Americans, Haitian 
Americans and Cuban Americans in the state of Florida may all have somewhat equal sun 
exposure in Miami throughout the year, with little seasonal variation. However, each 
ethnic group has different skin color: African Americans having the greatest amount of 
melanin compared to the majority of Cuban Americans who have the least amount of 
melanin and the fairest skin tone. African Americans are particularly at risk for vitamin D 
insufficiency because their darker skin color limits the amount of ultraviolet light that 
penetrates, thereby reducing cutaneous synthesis of vitamin D3 (Aloia et al., 2008). In 
fact melanin skin pigmentation is an effective natural sunscreen. Skin pigmentation can 
reduce the UVB from penetrating the skin by as much as 99% which has the same effect 
as applying sunscreen of factor 15 (Holick, 2006). It has been found that vitamin D3 
levels in Blacks are less than in Whites when exposed to usual levels of sun exposure; 
also, Blacks have been found to have lower serum 25(OH)D concentrations in winter and 
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summer compared to their White counterparts (Harris & Dawson-Hughes, 1998; Harris, 
Soteriadesm, Coolidge, Mudgal, & Dawson Hughes, 2000; Scragg, Sowers, & Bell, 
2004). Weaver and Fleet (2004) estimated that Blacks need 46–62 μg/d of vitamin D3 
supplementation. However, this assumption was made by Heaney, Davies, Chen, Holick 
and Barger-Lux (2003) and was based on a single study performed in white adults. 
Evidence and studies are currently lacking to make ethnically - specific recommendations 
for the required level of sun exposure or vitamin D intake at this time. 
 
Vitamin D deficiency in the elderly  
 Vitamin D is obtained either from the diet, synthesis in the skin by the action of 
sunlight or in a supplemental form. Older people tend to have reduced endogenous 
production of the vitamin for a variety of reasons; hence they become more dependent on 
dietary sources to maintain adequate vitamin D status (DOH, 1998). However, vitamin D 
from the sun and even dietary sources occurs only sporadically and irregular intake of 
vitamin D regardless of its source can lead to chronic vitamin D inadequacy (Holick, 
2006). Vitamin D deficiency, can particularly affect older adults since as people age, the 
skin cannot synthesize vitamin D as efficiently and the kidneys are less able to convert 
vitamin D to its active hormone form (Need, Morris, Horowitz, & Nordin, 1993). 
Decreased vitamin D in the elderly may be due to poor diet (Russell & Suter, 1993), 
being homebound or living in nursing homes (Webb, Kline, & Holick, 1990). In addition, 
the darker skinned elderly such as African Americans and Haitian Americans may be at 
even greater risk of vitamin D deficiency due to their increased skin pigment because 
ultraviolet rays-mediated synthesis of vitamin D is already greatly reduced (Clemens, 
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Adams, Henderson, & Holick, 1982). In addition, it has been found that up to 80 percent 
of Blacks and Hispanics have lactase deficiency so do not consume milk and cheese 
which have commonly fortified vitamin D (Swagerty, Walling, & Klein, 2002; Webb et 
al., 1990). Other reasons for lack of vitamin D from sun exposure are as follows: living in 
northern latitudes (for example New England), women who wear modest attire and head 
coverings for religious reasons, and people with occupations that prevent sun exposure 
(IOM, 1997; Webb, Kline, & Holick, 1988).  
 
Vitamin D receptor  
 The Vitamin D Receptor (VDR) is expressed in many cells, including β- cells of 
the pancreas and adipocytes; and, may therefore play a role in glucose homeostasis, 
insulin resistance and insulin secretion (Oh & Barrett-Connor, 2002; Tworowska-
Bardzinska, Lwow, & Kubicka, 2008). Vitamin D in the form of 1,25(OH)2D is mediated 
by VDR (Teegarden et al., 2009). Allelic differences in the VDR gene may also 
contribute to the genetic predisposition to certain diseases. As vitamin D modulates 
insulin secretion, it is feasible that genetic variants of the VDR gene may contribute to 
the development of T2D (Bid, Konwar, & Aggarwal, 2009). 
 
VDR polymorphisms and insulin secretion 
Vitamin D and its receptor complex may play a role in β-cell insulin secretion. 
There are three studies that looked at the association between VDR polymorphisms and 
insulin secretion. Hitman, Mannan, McDermott, Aganna, Ogunkolade, Hales and 
Boucher (1998) studied insulin secretion and its association with VDR polymorphism in 
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171 vitamin D deficient Bangladeshi Asian participants. Their findings indicated that 
there was an association between the VDR gene polymorphisms and insulin secretion 
particularly in the (AA) genotype. In contrast a later study conducted by Ogunkolade et 
al. (2002) found in 143 healthy Bangladeshis TaqI genotype independently predicted 
insulin secretion index, with (tt) genotypes showing the greatest insulin secretion index. 
One last study looked at VDR polymorphism of BsmI and its association with T2D and 
android type obesity. The study subjects consisted of 49 Caucasians with T2D, 29 with 
obesity but without T2D and 138 healthy subjects. It was found that highest postprandial 
C-peptide was in (BB) genotypes (wildtype homozygous genotype) that had T2D and 
obesity; thus, the VDR gene might play a role in the pathogenesis of T2D through the 
influence of β-cells secretory capacity (Speer et al., 2001). Although some studies have 
found a positive association with VDR polymorphisms and insulin secretion, there is a 
lack of studies indicating a consistent association. 
 
VDR polymorphisms and insulin resistance  
Low levels of Vitamin D may cause insulin resistance in the general population. It 
may also be one of the pathogenic mechanisms for abnormal glucose/insulin metabolism 
(Rammos, Tseke, & Ziakka, 2008). Few of the studies have looked at the association 
between insulin resistance and VDR polymorphisms, which may contribute to low levels 
of vitamin D regardless of diet, sun exposure and supplementation (Rammos et al., 2008). 
One study conducted with 49 healthy glucose tolerant Caucasians, assessed 
fasting insulin and glucose levels (Chiu, Chuang, & Yoon, 2001) found that FokI 
polymorphism at the VDR gene was associated with insulin sensitivity. The ff/Ff 
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genotypes had higher fasting insulin and HOMA- IR (insulin resistance) than (FF). Also 
the FokI genotype independently predicted HOMA-IR (but not beta cell function). 
The BsmI polymorphism frequency was assessed in 351 randomly selected Polish 
postmenopausal women where they found that BsmI is not associated with obesity and/or 
insulin resistance (Tworowska-Bardzinska, Lwow, & Kubicka, 2008). No difference was 
found in fasting insulin, glucose or fasting insulin resistance index between the genotypes 
(Alvarez & Ashraf, 2010), hence BsmI did not appear to be a predisposing factor for 
insulin resistance or obesity. Another study with the male Polish population investigated 
FokI and BsmI polymorphisms (Filus et al., 2008). Men (n = 176) were randomly 
selected and were between the ages of 25-65 years and with a mean BMI of 28.06 kg/m2. 
It was found that the VDR polymorphism BsmI  (BB) carriers seemed to have a higher 
BMI, whereas the FokI VDR polymorphism appeared to affect insulin sensitivity where 
the FF/ff genotype was associated with greater fasting insulin than (ff). BsmI was also 
measured in 1539 healthy male German soldiers with regard to their physical activity 
level (low and high) (Ortlepp, Metrikat, & Albercht, 2003). VDR genotype (BB) was 
associated with altered fasting blood glucose levels only in subjects with low physical 
activity.  
The Rancho Bernardo (2002) cross-sectional study of 1,545 older Caucasian 
adults found that although the frequencies of ApaI, BsmI and TaqI polymorphisms did not 
differ between persons with or without diabetes, the frequency of the (aa) genotype of 
ApaI polymorphisms was marginally higher in persons with T2D (p = 0.06) and fasting 
glucose was also higher in (aa) genotype of ApaI (Oh & Barrett-Connor, 2002). In 
contrast HOMA-IR was higher in (BB) genotype BsmI (Alvarez & Ashraf, 2010). The 
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authors indicate that ApaI polymorphism may be associated with glucose tolerance 
independent of defective insulin secretion; and, that BsmI polymorphism may be 
associated with insulin resistance (Oh & Barrett-Conor, p. 356).  
 Results from studies of insulin resistance, secretion and VDR polymorphisms, 
have been inconclusive and contradictory. Therefore further studies are needed to explore 
the relationship between VDR polymorphisms in genetically diverse populations.  
 
VDR polymorphisms and type 2 diabetes 
Although VDR gene is a candidate to study polymorphisms and its association 
with T2D, there are to date a few studies on the topic. Dilmec, Uzer, Akkafa, Kose and 
Van Kuilenburg (2010) aimed to investigate whether there was an association between 
the VDR gene and polymorphisms of ApaI and TaqI in a Turkish population with T2D. 
The research involved 241 participants, 72 with T2D and 169 healthy controls. Although 
the VDR genotype in patients with T2D was higher (19.4%) than those without T2D 
(11.2%) there were no significant differences. No evidence to support the association 
between ApaI and TaqI with T2D were found (Dilmec, Uzer, Akkafa, Kose, & Van 
Kuilenburg, 2010).  
Another study conducted in 1998 also looked at the ApaI and TaqI in 89 
Guadeloupe Indians with T2D and 100 controls; and they also found no statistical 
differences in genotype frequencies between cases and controls (Boullu-Sanchis, 
Lepretre, & Hedelin, 1999). However, a significant association of age (p = 0.002) and 
waist-hip ratio (p = 0.013) with TaqI genotypes of VDR gene polymorphism was present. 
Similar results were found by Malecki, Frey, and Moczulski (2003) with Polish adults. 
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Adults (n = 308) with T2D and controls (n = 240) were assessed for associations between 
T2D and Taq1, BsmI, FokI and ApaI and found that there was no association between the 
four examined VDR polymorphisms with T2D in the Polish population. 
 Ye, Reis, and Dubois-Laforgue (2001) examined BsmI, TruI, ApaI and TaqI in 
309 French subjects with T2D and in 143 controls; although no association was reported 
between the VDR gene and T2D the authors found VDR gene polymorphisms were 
associated with the susceptibility to obesity (BMI) in subjects with early-onset T2D.  
Finally, Vélayoudom-Céphise et al. (2011) in a cross-sectional study looked at 277 
Caribbean patients with T2D and assessed their vitamin D levels, VDR polymorphisms 
FokI, BsmI, ApaI and TaqI and cardiovascular risk factors. Findings indicated that FokI 
and ApaI polymorphism were associated with vitamin D deficiency and those participants 
carrying the (aa) genotype of the ApaI Single Nucleotide Polymorphism (SNP) or (f) of 
FokI SNP may be protective of vitamin D deficiency.  
Although the VDR gene is a good candidate for susceptibility to several diseases 
such as T2D (Dilmec et al., 2010), there has been little published data on VDR 
polymorphisms in the darker skinned populations (Vélayoudom-Céphise et al., 2011) or 
in Cuban Americans, Haitian Americans, and African Americans.  
In summary, there has been few published data on vitamin D, VDR 
polymorphisms and insulin resistance, insulin sensitivity and β-cell function in the darker 
skinned populations including Haitian Americans, and African Americans. Hispanic 
minorities such as Cuban Americans also have limited research where most studies focus 
on the Caucasian populations. It is therefore important to add to the growing body of 
knowledge on the role vitamin D, VDR polymorphisms and pancreatic function in the 
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progression of T2D in these ethnic groups, since evidence is still inconclusive and 
lacking. The results of this study will generate data to expand our existing knowledge of 
the role ethnicity plays in chronic diseases. It is anticipated that further exploratory 
studies will be needed before intervention studies can be designed and implemented. 
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III. SERUM VITAMIN D INSUFFICIENCY AND DIABETES STATUS IN 
THREE ETHNIC GROUPS 
Abstract 
Aim: To determine whether there is a relationship between 25-hydroxyvitamin D 
(25(OH)D) levels and ethnicity and whether the relationship varies by diabetes status. 
Methods: This cross sectional study included Haitian Americans (n = 253), Cuban 
Americans (n = 199), and African Americans (n = 248), with and without type 2 diabetes 
(T2D), from Florida, U.S. Participants were recruited through mailing lists (Cuban 
Americans and African Americans) and community-based sources (Haitian Americans). 
Information was obtained on participants’ socio-demographic data, smoking history, and 
medication(s) used. Height and weight were measured using a SECA balance scale (Seca 
Corp., Columbia, MD, U.S.). Body mass index (BMI) was calculated as weight in 
kg/height in m2. Dietary intake was measured using the semi-quantitative food frequency 
questionnaire. Serum 25(OH)D levels were determined using a commercial ELISA kit 
from Immunodiagnostic Systems Limited (Scottsdale, AZ, U.S.). This study was 
approved by the Institutional Review Board at Florida International University (Approval 
No. 011210-10). 
Results: Adjusted logistic regression analysis indicated that having T2D was associated 
with lower 25(OH)D levels as compared to participants without T2D regardless of 
ethnicity, age, gender, BMI, vitamin D intake, total calories intake, smoking, seasonal 
pattern (p < 0.001). Participants with T2D were 2.3 times more likely to have vitamin D 
insufficiency compared to participants without T2D, 95% CI (1.56 to 3.44). 
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Adjusted logistic regression analysis using Holms modified Bonferroni to correct for 
multiple comparisons indicated that there were significant differences in the odds of 
having insufficient 25(OH)D levels by ethnicity (p < 0.001), diabetes status (p < 0.001), 
and their interaction (p < 0.001). The covariates included in the model were age, gender, 
BMI, vitamin D intake, total calorie intake, smoking and seasons. Only Cuban Americans 
without T2D were significantly lower in the odds of having insufficient 25(OH)D from 
all other groups.  
Conclusion: Of the three ethnicities studied, Cuban Americans had the highest vitamin D 
levels regardless of diabetes status. Future studies should assess skin color, sun exposure 
and vitamin D receptor polymorphism and other factors that may have influenced the 
higher vitamin D levels in this ethnic group. Additionally, clinical studies may be 
warranted in ethnic groups to determine whether safe optimum doses of vitamin D could 
correct insufficiency and play a role in the prevention of T2D.  
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Introduction 
Low 25-hydroxyvitamin D (25(OH)D) levels have become an epidemic that only 
recently has been recognized in many populations around the world (Grant & Holick, 
2005). Blacks are particularly vulnerable to vitamin D insufficiency primarily due to their 
darker skin color, which limits the amount of ultraviolet light (UVB) that penetrates, in 
turn, reducing cutaneous synthesis of vitamin D3 (Forrest & Stuhldreher, 2011). Black 
Haitian Americans and African Americans and are usually placed in the same ethnic 
category in most studies and in data banks such as the National Health and Nutrition 
Examination Survey (NHANES) (Dawson-Hughes, 2004). As a result, few studies have 
been conducted on ethnic groups such as Haitian Americans as a subgroup of Blacks.  
Attention to minority groups is essential, in order to identify different 
characteristics distinctive perhaps to their ethnicity. For example, Haitian Americans 
have been found to have different diets and ethnic characteristics as compared to African 
Americans (CDC, 2011; De´silets, Rivard, Shatenstein, & Delisle, 2007; Scott, 
McDougle, Schwirian, & Taylor, 2010). Hispanics also exhibit a high prevalence of 
vitamin D deficiency (Forrest & Stuhldreher, 2011). Cuban Americans represent an 
important subgroup of Hispanics, with a total of 1.8 million residing in the United States 
in 2010, an increase of 44% since year 2000 (Ennis, Rios-Vargas, & Albert, 2011). 
Although the prevalence of diabetes among Cuban Americans (9%) is slightly lower than 
that of Puerto Ricans (11%) and Mexican Americans (10%) (Pabon-Nau, Cohen, Meigs, 
& Grant, 2010), the prevalence is still 1.3 to 1.5 times higher than among Whites (Stern 
& Mitchell, 1995). Cuban Americans represent the third largest Hispanic subgroup; 
however, there is limited research pertaining to vitamin D status or diabetes in this group 
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(Ennis, Rios-Vargas, & Albert, 2011). Hispanics and Blacks also have a higher risk of 
T2D as compared to Whites (CDC, 2011). The relationship between T2D and vitamin D 
has been associated with the function of the β-cells of the pancreas, where vitamin D 
levels have been found to be play an important role in insulin resistance, insulin 
sensitivity, and, possibly, the development of T2D (Baynes, Boucher, Feskens, & 
Kromhout, 1997; Gerich, 2003). Therefore, the objective of this study was to investigate 
the association between 25-hydroxyvitamin D (25(OH)D) levels and diabetes status in 
three ethnic groups: Cuban Americans, Haitian Americans, and African Americans. 
 
Methods 
Participants 
This cross-sectional study analyzed data from three ethnic minority groups with 
(n = 373) and without (n = 327) T2D, aged 35 years and older.  
 
Data Collection 
Participants were initially recruited by random selection from randomly generated 
mailing lists. The lists of addresses were purchased from Knowledge Base Marketing, 
Inc., Richardson, TX, U.S. Ten thousand letters, in English and Spanish along with an 
invitation flyer in both English and Spanish, were mailed to Cuban Americans. Of the 
participants who received letters, 4% (n = 388) responded. Additionally, approximately 
7,550 letters were mailed to African Americans with and without T2D. Of the 
participants who received letters, again 4% (n = 256) responded. Because we did not have 
a similar mailing list database for Haitian Americans, we recruited these participants 
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from community-based sources (n = 259): (a) local diabetes educators and community 
health practitioners in Miami-Dade and Broward Counties; (b) Florida International 
University faculty, staff, and students; (c) several active adult apartment complexes; and 
(d) print advertisements and radio advertisements. When the calculated sample size for 
each ethnic group yielded sufficient power to detect significance differences between 
major variables, including vitamin D, diabetes status, and ethnicity, the recruitment of 
participants was stopped.  
Interested participants were interviewed by phone, at which time the study 
purpose was explained and age, self-identified ethnicity (Cuban American, Haitian 
American, and African American), gender, self-reported T2D status (confirmed by 
fasting plasma glucose (> 126 mg/dL) and/or A1c (<6.5%), years since diagnosis, and 
initial treatment modalities (oral glucose-lowering drugs and insulin) were confirmed. 
Participants who did not qualify for the study (n = 28) were younger than 35 years old (n 
= 12), of another ethnicity (n = 5), or had a chronic disease or illness such as cancer, HIV 
infection, kidney failure, or hepatitis (n = 11), as these conditions could influence the 
main outcome of the study. This study was approved by the Institutional Review Board at 
Florida International University (Approval No. 011210-10). Written consent in English, 
Spanish, or Creole was obtained from the participants on their first visit to the laboratory. 
A total of 19 participants (Cuban Americans = 7; Haitian Americans = 8; and African 
Americans = 4) who reported not having diabetes were reclassified in the study as having 
T2D according to American Diabetes Association (ADA) standards. These participants 
were provided with a copy of their laboratory results and referred to their physicians. 
Participants with insufficient amounts of blood serum or an out-of-range coefficient of 
33 
 
variance were excluded (n = 160). A total of 700 participants (Cuban Americans = 199; 
Haitian Americans = 253; and African Americans = 248) were included in the final data 
analysis.  
 
Measures 
Participants were asked to complete standard self-administered questionnaires on 
site. For detailed questionnaires, trained interviewers were present to interview the 
participants and help them to complete the questionnaire. Data on participants’ socio-
demographic characteristics, smoking history, and medication(s) used were obtained. 
Height and weight were measured using a SECA balance scale with a stadiometer (Seca 
Corp, Columbia, MD, U.S.). Body mass index (BMI) was calculated as weight in 
kg/height in m2.  
 
Assessment of dietary intake 
Dietary intake was measured using the semi-quantitative food frequency 
questionnaire (FFQ; 97GP 2006 version copyrighted at Harvard University, Boston, MA, 
U.S.), developed by Walter C. Willett, which has been extensively validated and 
standardized in several multiethnic population-based studies (Satia-Abouta et al., 2003; 
Willet et al., 1985). Willett’s FFQ also has been validated exclusively for the Cuban 
American population (Nath & Huffman, 2005). On the FFQ, participants self-report 
average consumption of specified amounts of various foods and vitamins over the past 
year. Daily servings for food groups were calculated by summing frequency factors for 
all related food items. Macro- and micro-nutrient intakes were calculated by multiplying 
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frequency of consumption by the nutrient value of the food item obtained from the 
Harvard University Food Composition Database. Each of the completed FFQs was 
reviewed for incomplete answers or blank responses before the interview was completed.  
 
Blood collection 
Twenty ml of venous blood was collected from each participant, after an 
overnight fast (at least 8 hours), by a certified phlebotomist using standard laboratory 
techniques. Blood samples were collected in two tubes: a Vaccutainer Serum Separator 
Tube, (SST) for analysis of glucose and vitamin D, and another tube containing 
ethylenediamine tetra-acetic acid (EDTA) for the analysis of glycosylated hemoglobin 
(A1c). After complete coagulation (30-45 minutes), the SST sample was centrifuged at 
2,500 RPM for 30 minutes. The serum was transferred from the spun SST into one 
labeled plastic tube for glucose and vitamin D analysis. 
 Glucose levels were measured by hexokinase enzymatic methods. A1c 
percentages were measured from whole blood samples using the Roche Tina Quant 
method by Laboratory Corporation of America (LabCorp®), Miami, FL, U.S.  
Serum 25(OH)D levels were determined using a commercial ELISA kit from 
Immunodiagnostic Systems Limited (Scottsdale, AZ, U.S.). The manufacturer’s protocol 
was followed to perform this competitive assay, according to which the standards and 
samples were diluted with biotin-labeled 25(OH)D. For this study, the interassay 
coefficient of variation (CV) for ELISA of less than 10.3% was accepted (Bodnar et al., 
2007). The cutoff point for insufficient serum 25(OH)D levels was < 75 nmol/L (IOM, 
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2011). Serum 25(OH)D was used because it is considered the most reliable measure of 
overall vitamin D status (Misra, Pacaud, Petyk, Collett-Solberg, & Kappy, 2008).  
 
Data Analysis 
All statistical analyses were performed using SPSS (Version 18.0, Chicago, IL, 
U.S.). Differences in mean values by ethnicity and diabetes status were assessed using the 
Student’s t-test and analysis of variance (ANOVA), for numerical values, and χ2 test for 
categorical variables. Logistic regression analysis was used to determine the relationship 
between the dependent variable, serum 25(OH)D levels (sufficient/ insufficient), and the 
independent variables, ethnicity (Haitian American, Cuban American, and African 
American), diabetes status (yes/no), and their interaction. The final model was adjusted 
for potential socio-demographic, lifestyle, and physical factors (age, gender, BMI, 
vitamin D intake, total calorie intake, smoking, and season). The post-hoc Holm’s 
modified Bonferroni method was used to correct for multiple comparisons. Significance 
level for all analyses was set at p < 0.05. 
 
Results 
The study included 700 participants (Cuban Americans, Haitian Americans = 253, 
= 199, and African Americans = 248). Table 1 presents characteristics of study 
participants by ethnicity. Cuban Americans were significantly older and had a greater 
percentage of female participants than did Haitian and African Americans (p < 0.05). 
Cuban Americans also had significantly higher serum 25(OH)D levels compared to 
African Americans and Haitian Americans (p < 0.05). African Americans had a 
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significantly higher BMI, a higher proportion of smokers, and a higher caloric intake as 
compared to Cuban Americans and Haitian Americans (p < 0.05). Additionally, African 
Americans had a higher vitamin D intake than did Haitian Americans and Cuban 
Americans (p < 0.05). 
Table 2 shows the characteristics of study participants by diabetes status. 
Participants with T2D were significantly older (p < 0.001), had a higher BMI (p < 0.001), 
had lower caloric intake (p = 0.005), and had lower serum 25(OH)D levels (p < 0.001) as 
compared to participants without T2D.  
There were significant differences in age, BMI, ethnicity, diabetes status, and 
season by vitamin D status (Table 3). Participants in the insufficient 25(OH)D group 
were significantly younger (p = 0.003) and had a higher BMI (p < 0.001). This group also 
had a lower percentage of Cubans Americans (p < 0.001) and a higher percentage of 
individuals with T2D (p < 0.001). A greater percentage of those tested in the spring-
summer season were sufficient (31.1%) than were those tested in the winter (18.5%) 
 (p <0.001).  
Adjusted logistic regression analysis indicated that having T2D was associated 
with lower 25(OH)D levels as compared to participants without T2D regardless of 
ethnicity, age, gender, BMI, vitamin D intake, total calories intake, smoking, seasonal 
pattern (p < 0.001). Participants with T2D were 2.3 times more likely to have vitamin D 
insufficiency compared to participants without T2D, 95% CI (1.56 to 3.44)(not shown). 
Table 4 shows the adjusted logistic regression analysis using the Holm’s modified 
Bonferroni method to correct for multiple comparisons. The adjusted logistic regression 
indicated significant differences in the odds of having insufficient 25(OH)D levels by 
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ethnicity [χ2 (df = 2, N = 700) = 80.0, p < 0.001], diabetes status [χ2 (df = 1, N = 700) = 
45.0, p < 0.001], and their interaction [χ2 (df = 2, N = 700) = 37.8, p < 0.001]. This model 
included covariates (age, gender, BMI, vitamin D intake, total calorie intake, smoking 
and seasons) which were statistically significant [χ2 (df = 12, N = 700) = 157, p < 0.001] 
and explained 29.6% of the variance of 25(OH)D levels (Nagelkerke pseudo R-square); 
only Cuban Americans without T2D had lower odds of being vitamin D insufficient than 
Cuban Americans with T2D and African Americans and Haitian Americans with and 
without T2D. 
 
Discussion 
Our study found significant differences in vitamin D levels across diabetes status 
and ethnic groups. Primarily, we found that participants with T2D had lower serum 
25(OH)D levels (p < 0.001) compared to participants without T2D, which is in agreement 
with previous research (Baynes et al., 1997). The mechanism of action of vitamin D in 
diabetes is not completely understood in humans; however, it is thought that vitamin D 
deficiency impairs insulin synthesis and secretion in β- cells of the pancreas, which 
results in the development of T2D (Gerich, 2003).  
Additionally, Cuban Americans without T2D had the highest vitamin D levels as 
compared to Haitian Americans and African Americans. These differences among 
ethnicities may be caused by a number of factors. First, lower vitamin D levels in 
participants with black skin color (African Americans, and Haitian Americans) may be 
directly associated with their skin color. Nesby-O’Dell et al. (2002) reported that 10 
times as many African American women as white women were deficient in vitamin D (≤ 
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37.5 nmol/L). Due to their darker skin, Blacks require greater sunlight exposure, as 
melanin skin pigmentation is an effective natural sunscreen. Darker-pigmented 
individuals would require longer periods of time in the sun (Zittermann, 2003). Second, 
Blacks may have limited absorption, resistance, or decreased ability to synthesize vitamin 
D in the body (Dawson- Hughes, 2004). Third, vitamin D receptor (VDR) 
polymorphisms may create metabolic disturbances, variations in insulin secretion, and 
genetic susceptibility to T2D (Ogunkolade et al., 2002). Fourth, based on our study 
African Americans had the highest BMI. It has been reported that there is an inverse 
association between serum 25(OH)D and BMI (Arunabh, Pollack, Yeh, & Aloia, 2003), 
whereby, it is proposed, that vitamin D is sequestered in fat cells (Need, Morris, 
Horowitz, & Nordin, 1993) and, with increased fat in the body, circulating vitamin D 
levels decrease.  
The Third National Health and Nutrition Examination Survey found ethnic 
variations in 25(OH)D levels, whereby Whites had the highest 25(OH)D concentrations, 
followed by Mexican Americans and then Blacks, who had the lowest levels (Scragg et 
al., 2004). These results are in accordance with our study, which found that African 
Americans and Haitian Americans were most likely to have vitamin D insufficiency, with 
Cuban Americans being the least likely to have vitamin D insufficiency. Although skin 
pigmentation was not measured in our cohort, it was observed that all of the Cuban 
American participants had white skin pigmentation, which may have allowed them 
greater UVB exposure as compared to the Haitian Americans and African American 
participants. 
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Interestingly, in our study, and contrary to the findings in regard to Cuban 
Americans and African Americans, we found that Haitian Americans without diabetes 
were at the greatest risk for 25(OH)D insufficiency, when compared to Cuban Americans 
without T2D. However, differences in 25(OH)D in Haitian Americans with and without 
diabetes were not significantly different.  
We did not find any association between covariates and the presence of T2D or 
vitamin D status to explain the increased vitamin D insufficiency found in the Haitian 
Americans without T2D. Therefore, we hypothesize that our findings for Haitian 
Americans may be due to skin color or genetic factors. These results also may be specific 
to the cohort that we studied and, as such, the findings cannot be generalized to other 
Haitians living in the U.S.  
Participants in the insufficient 25(OH)D group were younger as compared to the 
sufficient group. Generally, it has been found that vitamin D deficiency can particularly 
affect older adults; as the skin ages, it cannot synthesize vitamin D as efficiently, and the 
kidneys are less able to convert vitamin D to its active hormone form (Need et al., 1993). 
In addition, our study found that African Americans had the highest intake of vitamin D 
as compared to their counterparts. The higher vitamin D intake was not the result of 
dietary supplementation; thus, it may have been due to the increased caloric intake 
demonstrated in this African American cohort (~2569kcal/day). However, this finding is 
contradictory to the findings of other studies, which have found that African Americans 
normally have low intakes of vitamin D because commonly fortified foods that contain 
vitamin D, such as milk and cheese, contain lactose; and it has been reported that up to 
80% of Blacks and Hispanics have lactase deficiency (Swagerty, Walling, & Bell, 2004). 
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Data collection during spring-summer months showed that fewer participants had 
insufficient 25(OH)D compared to sufficient. Our results are consistent with those of 
Scragg et al. (2004), who also found a seasonal pattern, with 25(OH)D levels being 
higher in the summer months. Higher 25(OH)D levels in spring-summer months may be 
an indicator that more people are exposed to sun during this time and, thus, are less likely 
to have 25(OH)D insufficiency. 
From our total cohort we can conclude that having T2D was associated with 
lower 25(OH)D levels after adjustment for covariates . However, we did not control for 
sun exposure and other unknown factors that may have affected vitamin D levels.  The 
possibility that skin color may play an important role with regards to vitamin D levels 
requires further exploration with direct measures of skin color. In addition, genetic 
factors, quality of diet and lifestyle factors may each have an individual or combined 
effect on specific ethnic groups.  For example our study found that although both Haitian 
Americans, and African Americans are Black they still possess other factors that make 
them unique to one another. African Americans had the highest BMI, energy intake, 
percentage of smokers and vitamin D intake, whereas Haitian Americans had the lowest 
BMI, energy intake, percentage of smokers and vitamin D intake. We did not find 
statistically significant differences amongst Haitian Americans and African Americans 
but rather found that both groups were highly likely to have 25(OH)D insufficiency. 
This study had some significant strengths. It is the first study that distinguishes 
two Black groups (Haitian Americans and African Americans) as separate and 
independent ethnicities (with regard to vitamin D and diabetes status) and, as such, yields 
important information on ethnic differences. It also looks at the relationship between 
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ethnicity, diabetes status, and serum vitamin D levels, which provides insight into how 
the variables interact with one another. 
There are a number of potential limitations in this study. First, sun exposure and 
skin color were not measured. This information could have provided an additional 
understanding of the role that these factors may have on vitamin D status. Second, dietary 
intake was self-reported; it is possible that dietary intake may have been over- or 
underestimated by different ethnic groups. However, the FFQ used has been validated in 
the Cuban American population (Nath & Huffman, 2005) and in other multiethnic 
population-based prospective and cross-sectional studies (Satia-Abouta et al., 2003; 
Willet & Sampson, 1985). Third, parathyroid hormone levels were not assessed in this 
study, which may have provided a better understanding of the vitamin D regulation in the 
three ethnicities.  
Our findings indicate that being African American or Haitian American increases 
the likelihood of vitamin D insufficiency. We postulate that ethnicity, diabetes status, and 
possibly skin color contributed to our findings; however the association is still unclear. 
Vitamin D status is an important parameter that needs to be assessed in individuals at 
high risk for vitamin D insufficiency. Clinical studies may be warranted to determine 
whether safe optimum doses of vitamin D could correct insufficiency and play a role in 
the prevention of T2D. Future studies also may benefit from an examination of 
acculturation factors such as time of immigration, length of stay, and living dynamics of 
Haitian Americans and Cuban Americans, which may affect dietary intake and risk of 
disease. Other genetic factors, such as vitamin D receptor polymorphisms, may affect 
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vitamin D status and may play a role in the progression of T2D. Because evidence is still 
inconclusive or lacking, further research is recommended. 
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Table 1. Characteristics of study participants by ethnicity 
 
 Ethnicity  
 Cuban Americans Haitian Americans African Americans  
Variables (n = 199) (n = 253) (n = 248) p
Age (years) 62.8 ± 11.6a 56.0 ± 10.7b               52.7 ± 9.5c <0.001 
Gender (M) (%) 36.7b                 47.4a 49.2a 0.019 
BMI (kg/m2)            31.4 ± 6.0b             29.2 ± 5.2c               33.5 ± 7.9a <0.001 
Smoking (yes) (%) 13.1b 6.3c 37.9a <0.001 
T2D status (yes) (%)                 55.3                  53.0                    52.0 0.784 
Energy intake (kcal/d)        2264.9 ± 795.6b 1817.5 ± 1104.2c 2569.1 ± 1834.1a <0.001 
Vitamin D intake (IU/d) 449.0 ± 340.3b 379.1 ± 356.8c 537.4 ± 474.1a <0.001 
Vitamin D intake w/o suppl. (IU/d)          277.6 ± 177.1           277.6 ± 265.4             318.5 ± 309.6 0.142 
25(OH)D (nmol/L) 82.1 ± 34.8a 56.3 ± 19.4b 54.2 ± 23.8b <0.001 
Vitamin D suppl. (yes) (%) 2.5 6.3                    12.5 <0.001 
 
Data are means ± SD unless otherwise indicated. Ethnic groups with different superscripts are significantly different from each other. 
Holm’s modified Bonferroni method was used to correct for multiple comparisons. p is considered significant at < 0.05. Abbreviations:  
T2D = Type 2 diabetes; BMI = body mass index; 25(OH)D = 25-hydroxyvitamin D; w/o = without; suppl = supplements.
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Table 2. Characteristics of study participants by diabetes status 
 
 Participants  
 without T2D with T2D  
Variables (n = 327) (n = 373) p
Age (years)         54.6 ± 10.7 58.7 ± 11.5 <0.001 
Gender (M) (%) 45.6             44.5 0.778 
BMI (kg/m2)         30.0 ± 5.6        32.6 ± 7.4 <0.001 
Smoking (yes) (%) 20.2             18.8 0.636 
Energy  intake (kcal/d)     2368.6 ± 1450.7 2072.8 ± 1305.3 0.005 
Vitamin D intake (IU/d)       474.5 ± 409.0 438.1 ± 397.9 0.229 
Vitamin D intake w/o suppl. (IU/d)       297.2 ± 279.4 287.6 ± 245.6 0.630 
25(OH)D (nmol/L)         70.1 ± 33.3 56.6 ± 22.2 <0.001 
Vitamin D suppl. (yes) (%)  9.2  5.9 0.099 
 
Data are means ± SD unless otherwise indicated. p is considered significant at < 0.05. 
Abbreviations: T2D = Type 2 diabetes; BMI = body mass index; 25(OH)D = 25-hydroxyvitamin 
D; w/o = without; suppl = supplements.
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Table 3. Characteristics of study participants by 25-hydroxyvitamin D status 
 
 25(OH)D status  
 Insufficient Sufficient  
Variables (n = 522) (n = 178) p
Age (years) 56.0 ± 11.6 58.9 ± 10.1 0.003 
Gender (M) (%) 44.3 47.2 0.496 
BMI (kg/m2)          31.9 ± 7.0         29.8 ± 5.4 <0.001 
Ethnicity (%)   <0.001 
     Cuban American 19.5 54.5  
     Haitian American 40.6 23.0  
     African American 39.8 22.5  
T2D status (yes) (%) 58.2 38.8 <0.001 
Smoking (yes) (%) 20.3 16.9 0.315 
Energy intake (kcal/d) 2207.1 ± 1456.5 2222.3 ± 1139.5 0.899 
Inadequate vitamin D intake (%) 57.1              51.7 0.210 
Vitamin D suppl. (yes) (%)   7.7  6.7 0.686 
Season (spring-summer) (%) 51.0              67.4 <0.001 
 
Data are means ± SD unless otherwise indicated. p is considered significant at < 0.05. 
Abbreviations: T2D = Type 2 diabetes; BMI = body mass index; suppl = supplements; 25(OH)D 
= 25-hydroxyvitamin D. Serum 25-hydroxyvitamin D insufficiency <75 nmol/L; inadequate 
vitamin D intake (<400 IU/d). 
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Table 4. Odds of having insufficient 25-hydroxyvitamin D by ethnicity and diabetes status 
 
Groups OR 95% CI p 
CA without T2D Referencea                  - - 
CA with T2D 10.57b 5.31 - 21.05 <0.001 
AA without T2D 13.14b 6.39 - 27.03 <0.001 
HA with T2D 15.67b 7.65 - 32.09 <0.001 
AA with T2D 24.37b        10.51 - 56.54 <0.001 
HA without T2D 31.75b        14.17 - 71.14 <0.001 
 
aReference category for p value. Groups with different superscripts are significantly different 
from each other, using the Holm’s modified Bonferroni method to correct for multiple 
comparisons. Adjusted logistic regression analysis indicated significant differences in the odds of 
having insufficient 25(OH)D levels by ethnicity [χ2 (df = 2, N = 700) = 80.0, p < 0.001], diabetes 
status [χ2 (df = 1, N = 700) = 45.0, p < 0.001], and their interaction [χ2 (df = 2, N = 700) = 37.8, p 
< 0.001]. The model included covariates (age, gender, BMI, vitamin D intake, total calorie intake, 
smoking and season) was statistically significant [χ2 (df = 12, N = 700) =157, P < 0.001] and 
explained 29.6% of the variance of 25(OH)D levels (Nagelkerke pseudo R-square). 
Abbreviations: T2D = Type 2 diabetes
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IV.  VITAMIN D RECEPTOR POLYMORPHISMS, VITAMIN D LEVELS, 
AND DIABETES STATUS IN THREE ETHNIC GROUPS 
Abstract 
Aim: To assess the relationship between serum 25(OH)D levels, vitamin D receptor 
(VDR) polymorphisms (BsmI, TaqI and ApaI), and diabetes status in three ethnic groups 
(Cuban Americans, Haitian Americans, and African Americans) residing in South 
Florida.  
Methods: This cross-sectional study included 749 participants (Cuban American = 267; 
Haitian American = 245; African American = 237) with and without type 2 diabetes 
(T2D) from Florida, U.S. Participants were recruited through mailing lists (African 
Americans and Cuban Americans) and community-based sources (Haitian Americans). 
Information was obtained on participants’ sociodemographic data, smoking history, and 
medication(s) used. Height and weight were measured using a SECA balance scale (Seca 
Corp., Columbia, MD, U.S.). Body mass index (BMI) was calculated as weight in 
kg/height in m2. Dietary intake was measured using a semi-quantitative food frequency 
questionnaire. Serum 25(OH)D levels were determined using a commercial ELISA kit 
from Immunodiagnostic Systems Limited (Scottsdale, AZ, U.S.). The single nucleotide 
polymorphisms (SNPs) BsmI, TaqI, and ApaI were genotyped using PCR-RFLP and RT-
PCR. All statistical analyses were performed using SPSS (Version 18.0, Chicago, IL, 
U.S.). For statistical analysis, Student’s t-test, analysis of variance (ANOVA), χ2 test, and 
logistic regression analysis were used. This study was approved by the Institutional 
Review Board at Florida International University (Approval No. 011210-10). 
51 
 
Results: The study included 749 participants genotyped for BsmI and TaqI, and 734 
participants for ApaI polymorphism. BsmI polymorphism was not in Hardy-Weinberg 
equilibrium and was excluded from the study. TaqI and ApaI genotype frequencies 
showed significant differences by ethnicity (p < 0.001), with Cuban Americans having a 
higher percentage of (tt) (12.4%), compared to African Americans (2.5%) and Haitian 
Americans (6.5%). After controlling for age, gender, and BMI, only Cuban Americans 
with T2D were 7.3 times more likely to be vitamin D insufficient 95% CI (1.97 to 26.9) 
(p = 0.003) if they had TaqI (TT) and (Tt). Participants with T2D had lower serum 
25(OH)D (p < 0.001) levels than did those without T2D. There were no significant 
differences in combined genotype frequency of TaqI and ApaI by diabetes status.  
Conclusion: TaqI was found to be associated with vitamin D and ethnicity; it appears 
that the (tt) genotype in Cuban Americans may be protective against vitamin D 
insufficiency. In comparison, ApaI was not associated with T2D or vitamin D levels in 
our cohort of Cuban Americans, Haitian Americans, or African Americans. Further work 
is needed to assess how the TaqI (tt) genotype is associated with higher vitamin D levels 
in Cuban Americans with T2D. Additionally, there is a need to explore how other 
potential VDR SNPs may influence or enhance plasma vitamin D levels. 
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Introduction   
There has been a growing interest in the association between type 2 diabetes 
(T2D) risk and vitamin D levels. This association relates to the function of the β-cells of 
the pancreas, where low vitamin D levels are found to alter insulin resistance, secretion, 
and sensitivity and lead to impaired glucose metabolism (Baynes, Boucher, Feskens, & 
Kromhout, 1997; Chiu, Chu, Go, & Saad, 2004; Filus et al., 2008; Gerich, 2003). After 
Vitamin D is obtained from ultraviolet-B (UVB) sun exposure, food, and supplements, it 
is biologically inert and must undergo two hydroxylations in the body for activation. The 
first occurs in the liver, where vitamin D is converted into 25-hydroxyvitamin D (25(OH) 
D). The second hydroxylation occurs primarily in the kidneys, where it is enzymatically 
converted to the physiologically active 1,25-dihydroxyvitamin D (1,25(OH)2D) (Mathieu, 
Gysemans, Bouillon, & Bouillon, 2005).  
Serum 1,25(OH)2D is the biologically active hormone form of vitamin D, and its 
mechanism of action is mediated by binding to the vitamin D receptor (VDR), where 
1,25(OH)2D can then exert its actions on target tissue (Palomer, Gonzalez, Blanco-Vaca, 
& Mauricio, 2008). VDR functions as a ligand-dependent transcription factor for many 
genes that can bind to a number of vitamin D metabolites. Because vitamin D deficiency 
impairs insulin synthesis and secretion of β-cells of the pancreas (Gerich, 2003), and the 
VDR is expressed in many cells, including the β-cells of the pancreas, VDR could play a 
direct role in glucose homeostasis, insulin resistance, and insulin secretion (Oh & Barrett-
Connor, 2002). It is feasible that genetic variants of the VDR gene may contribute to the 
development of T2D (Bid et al., 2009), especially because it has been found that variants 
near genes involved in vitamin D transport affect vitamin D status (Wang, 2010). Few 
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studies have addressed the relationships among vitamin D levels, VDR polymorphisms, 
and diabetes. Vélayoudom-Céphise et al. (2011) indicated that, in participants with T2D, 
the single nucleotide polymorphisms (SNP) at ApaI and FokI restriction sites were 
associated with vitamin D deficiency, where the (aa) genotype of the ApaI and the (Ff or 
ff) genotypes of FokI SNP were found to be protective against vitamin D deficiency.  
Different ethnicities may have variable levels of 25(OH)D, with a higher 
prevalence of vitamin D insufficiency in African Americans, Hispanics, and individuals 
with a high melanin concentration (Forrest & Stuhldreher, 2011). Low serum 25(OH)D in 
darker-skin individuals is attributed to the diminished synthesis of vitamin D due to high 
pigmentation of the skin (Bell, 1985).  
The most commonly examined polymorphisms of the VDR gene are BsmI 
(rs1544410) TaqI (rs731236) and ApaI (rs7975232) (Seshadri & Tamilselvan, 2011), 
located on the 3’ untranslated (UTR) region of the VDR gene. Although polymorphisms 
begin as mutations in a population, with time, they become true polymorphisms and may 
be associated with certain ethnicities. Thus, differences in the frequency of alleles among 
ethnic groups may result from the evolutionary processes and genetic behavior of the 
population (Uitterlinden, Fang, Van Meurs, Pols, & Van Leeuwen, 2004). So far, little is 
known about the relationship between ethnicity and VDR polymorphisms. Most studies 
have been in Caucasian populations. Blacks and Caribbeans have been studied to a lesser 
extent (Maleki, Frey, Moczulski, Klupa, Kozek, & Sieradzki, 2003; Uitterlinden et al., 
2004; Vélayoudom-Céphise et al., 2011).  
The aim of this study, therefore, was to assess the relationship between serum 
25(OH)D levels, VDR polymorphisms (BsmI, TaqI and ApaI), and diabetes status in 
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three ethnic groups (Cuban Americans, Haitian Americans, and African Americans) who 
reside in South Florida. The three groups comprise a diverse population, representing 
differing ethnicities, skin pigmentations, and, likely, genetic predispositions. 
 
Methods 
Participants 
In this cross-sectional study, data were from three ethnic minority groups, with (n 
= 365) and without (n = 384) T2D, aged 35 years and older.  
 
Data Collection 
Participants were initially recruited by random selection from randomly generated 
mailing lists, purchased from Knowledge Base Marketing, Inc., Richardson, TX, U.S. 
Ten thousand letters, along with an invitation flyer in both English and Spanish, were 
mailed to Cuban Americans. Of the participants who received letters, 4% (n = 388) 
responded. Additionally, approximately 7,550 letters were mailed to African Americans 
with and without T2D. Of the participants who received letters, again 4% (n = 256) 
responded. Because we did not have a similar mailing list database for Haitian 
Americans, we recruited these participants from community-based sources (n = 259): (a) 
local diabetes educators and community health practitioners in Miami-Dade and Broward 
Counties; (b) Florida International University faculty, staff, and students; (c) several 
active adult apartment complexes; and (d) print advertisements and radio advertisements. 
When the calculated sample size for each ethnic group yielded sufficient power to detect 
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significance differences between major variables, the recruitment of participants was 
discontinued.  
Interested participants were interviewed by phone, at which time the study 
purpose was explained and age, self-identified ethnicity (Cuban American, Haitian 
American, and African American), gender, self-reported T2D status (confirmed by 
fasting plasma glucose (>126 mg/dL) and/or A1c (<6.5%), years since diagnosis, and 
initial treatment modalities (oral glucose-lowering drugs and insulin) were confirmed. 
Participants who did not qualify for the study (n = 28) were younger than 35 years old (n 
= 12), of another ethnicity (n = 5), or had a chronic disease or illness such as cancer, HIV 
infection, kidney failure, or hepatitis (n = 11), as these conditions could influence the 
main outcome of the study. This study was approved by the Institutional Review Board at 
Florida International University (Approval No. 011210-10). Written consent in English, 
Spanish, or Creole was obtained from the participants on their first visit to the laboratory. 
A total of 19 participants (Haitian Americans = 8; Cuban Americans = 7; and African 
Americans = 4) who reported not having diabetes were reclassified in the study as having 
T2D according to American Diabetes Association (ADA) standards.  These participants 
were provided with a copy of their laboratory results and referred to their physicians. 
Participants with insufficient amounts of blood serum, out-of-range coefficient of 
variance, or missing or out-of-range VDR values were excluded. A total of 749 
participants (Cuban American = 267; Haitian American =245; African American =237) 
were included in the final data analysis.  
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Measures 
Participants were asked to complete standard self-administered questionnaires on 
site. For detailed questionnaires, trained interviewers were present to interview the 
participants and help them to complete the questionnaire. Data on participants’ 
sociodemographic characteristics, smoking history, and medication(s) used were 
obtained. Height and weight were measured using a SECA balance scale with a 
stadiometer (Seca Corp., Columbia, MD, U.S.). Body mass index (BMI) was calculated 
as weight in kg/height in m2. 
 
Blood collection 
Twenty ml of venous blood were collected from participants after an overnight 
fast (at least 8 hours) by a certified phlebotomist using standard laboratory techniques. 
Blood samples were collected in two tubes: a Vaccutainer Serum Separator Tube (SST), 
for analysis of glucose and vitamin D, and another tube containing ethylenediamine tetra-
acetic acid (EDTA) for the analysis of glycosylated hemoglobin (A1c). After complete 
coagulation (30-45 minutes), the SST sample was centrifuged at 2,500 RPM for 30 
minutes. The serum was transferred into a labeled plastic tube and stored at -70°C until 
used. 
 
Determination of glucose and vitamin D levels 
Glucose levels were measured by hexokinase enzymatic methods. A1c 
percentages were measured from whole blood samples with the Roche Tina Quant 
method by Laboratory Corporation of America (LabCorp, Miami, FL, U.S.). Serum 
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25(OH)D levels were determined using a commercial ELISA kit from Immunodiagnostic 
Systems Limited (Scottsdale, AZ, U.S.). The manufacturer’s protocol was followed to 
perform this competitive assay, according to which the standards and samples were 
diluted with biotin-labeled 25(OH)D. For this study, the interassay coefficient of 
variation (CV) for ELISA was accepted at less than 10.3% (Bodnar et al., 2007). The 
cutoff point used to determine insufficient serum 25(OH)D levels was <75 nmol/L (IOM, 
2011). 
 
SNP genotyping 
Blood samples were collected from each subject, and a proper amount of aliquot 
(400µl) was placed in 2.0ml cryo vials and stored at -70°C until DNA extraction. Total 
DNA (a mixture of genomic DNA and mitochondrial DNA) was extracted from the 
whole blood collected, according to the instructions of the user manual of the DNA 
extraction kit (QIAGEN, Valencia, CA, U.S.). The extracted DNA samples were stored at 
-20°C after measurements of DNA concentration. 
Polymerase chain reaction-restriction fragment length polymorphism (PCR- 
RFLP) was used for genotyping BsmI and TaqI, and RT-PCR was used for ApaI. PCR 
amplification was performed with PCR supermix high fidelity that contained 1.5 mM 
Mg2+ and two gene-specific primers. Primer sets purchased from Invitrogen/Life 
Technologies, Carlsbad CA, U.S., were as follows: for BsmI genotype, 
5’CAACCAAGACTACAAGTACCGCGTCAGTGA-3’ (sense) and 5’-
AACCAGCGGAAGAGGTCAAGGG-3’ (antisense) (NCBI, 2012); for genotypes of 
TaqI,  5’-GGTGGGATTGAGCAGTG-3’ (sense) and 5’-ATGCTGCACTCAGGCTG-3’ 
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(antisense), as described elsewhere (Oh & Barrett-Connor, 2002). The gene-specific 
primers for BsmI in this paper were designed based on GenBank nucleotide sequence 
databases with the following accession number: NG_008731, Homo sapien vitamin D 
(1,25- dihydroxyvitamin D3) receptor (VDR), RefSeqGene on chromosome 12. Forward: 
58336- 58365. Reverse: 59136-59157 (NCBI, 2012). 
PCR conditions for BsmI genotype were as follows: initial denaturation of 1 cycle 
for 3 min at 94°C; 39 cycles at 94°C for 30 sec, 55°C for 30 sec, and 72°C for 60 sec; 
final elongation of 1 cycle at 72°C for 4 min. PCR conditions for TaqI genotype were as 
follows: initial denaturation of 1 cycle for 3 min at 94°C; 39 cycles at 94°C for 30 sec, 
57°C for 30 sec, and 72°C for 60 sec; final elongation of 1 cycle at 72°C for 4 min. 
The PCR products (15µl per sample) were digested for 5 hours at 65°C, with 
respective restriction enzymes BsmI (7.5 units) and TaqI (7.5 units) purchased from New 
England BioLabs (Ipswich, MA, U.S.). All products were separated by gel 
electrophoresis on 2% agarose gel in 1x TAE buffer and visualized by ethidium bromide 
staining under ultraviolet light. 
DNA fragments of the SNP ApaI were amplified from genomic DNA by TaqMan 
allelic discrimination assay. PCR amplification was as follows: Pre-PCR read of 1 cycle 
for 30 seconds at 60°C; holding stage of 1 cycle for 10 minutes at 95°C; 40 cycles for 15 
seconds at 95°C and 1 minute at 60°C; post-PCR of 1 cycle at 60°C for 30 seconds and 
ending the reaction at 4°C holding. The SNPs BsmI and TaqI were amplified using the 
PCR- RFLP because there was not enough specificity provided by RT-PCR. 
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Data analysis 
All statistical analyses were performed using SPSS (Version 18.0, Chicago, IL, 
U.S.). Differences in mean values among ethnicities and diabetes status were assessed 
using the Student’s t-test and analysis of variance (ANOVA) for numerical values and χ2 
test for categorical variables. Stratification by ethnicity was necessary for data analysis, 
as VDR act differently in varied population groups and ethnicities (Uitterlinden et al., 
2004). Logistic regression analysis was used to determine the relationship of serum 
25(OH)D levels (sufficient/ insufficient), diabetes status (yes/no), SNP polymorphism 
(wildtype homozygote, heterozygote, variant homozygote) for genotypes TaqI and ApaI, 
respectively, and their interactions. All final models were adjusted for age, gender, BMI, 
and vitamin D intake. 
 
Results 
The study included 749 participants genotyped for BsmI and TaqI, and 734 
participants for ApaI polymorphism. Hardy-Weinberg equilibrium (HWE) was assessed 
prior to data analysis. The vitamin D receptor genotype BsmI in the control group 
(without T2D) was not in HWE and, therefore, was excluded from further analysis. TaqI 
and ApaI for those without T2D were in HWE. Table 1 presents descriptive statistics by 
T2D status. Participants with T2D were older (p < 0.001), had higher BMI (p < 0.001) 
and lower serum 25(OH)D (p < 0.001) levels than did those without T2D. There were no 
significant differences in combined genotype frequency of TaqI and ApaI by diabetes 
status.  
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Table 2 shows the descriptive statistics by VDR genotypes. Distribution of TaqI 
and ApaI genotypes differed by ethnicity (p < 0.001), with Cuban Americans having a 
higher percentage of variant homozygosity (12.4%), compared to African Americans 
(6.5%) and Haitian Americans (5.5%). Only the TaqI SNP showed a statistically 
significant difference between participants with sufficient and insufficient 25(OH)D 
levels (p = 0.05), with only 6.9% of the insufficient being variant homozygote compared 
to 12.6% of the sufficient. 
Table 3 shows descriptive statistics within each ethnicity by vitamin D status. 
Cuban Americans who were vitamin D insufficient were significantly older (p < 0.001) 
and had a higher percentage of T2D (p < 0.001), compared with the sufficient group. 
TaqI genotypes were significantly associated with vitamin D levels (p = 0.01), with a 
smaller percentage (8.5%) of those who were vitamin D insufficient carrying the variant 
homozygote genotype than those who were sufficient (18.6%). Haitian Americans in the 
vitamin D insufficient group had a lower proportion of T2D (p = 0.04) than did the 
vitamin D sufficient group. African Americans in the vitamin D insufficient group were 
significantly younger (p = 0.04), had a greater percentage of females (p = 0.01), higher 
BMI (p < 0.01), and higher percentage of T2D (p = 0.03) than did the vitamin D 
sufficient group.  
The relationship of TaqI distribution in Cuban Americans was examined by 
diabetes status separately, and a significant difference was found in those with T2D (p = 
0.02). Figure 1 shows the distribution of vitamin D status across VDR genotypes among 
Cuban Americans with T2D. The TaqI variant homozygosity had the lowest frequency in 
the participants with vitamin D insufficiency, compared to the wildtype homozgosity and 
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heterozgosity (p < 0.05). An unadjusted odds ratio indicated that Cuban Americans with 
T2D were 5.4 times more likely to be vitamin D insufficient, 95% CI (1.6 to 18.7) if they 
had TT and Tt. The odds further increased to 7.3 95% CI (2.0 to 26.9) (p = 0.003) after 
controlling for age, gender and BMI.  
 
Discussion 
There was no direct association between TaqI and ApaI polymorphisms with 
diabetes status. TaqI genotype frequencies were marginally significantly different 
between vitamin D sufficient and insufficient subjects. Additionally, ethnicity was 
significantly associated with both TaqI and ApaI genotypes. Our main significant finding 
was the frequency of the TaqI variant homozygote (tt) association with vitamin D levels, 
where a smaller percentage of those who were vitamin D insufficient carried (tt), as 
compared to those who were sufficient. Hence, it appears that the (tt) genotype in Cuban 
Americans may be protective against vitamin D insufficiency. Although this mechanism 
is still unclear, prior studies have indicated the ability of this SNP to alter transcriptional 
activity and mRNA stability, thereby altering the abundance of VDR and vitamin D 
levels (Howard et al., 1995; Morrison, 1994; Orton et al., 2008). However, Vélayoudom-
Céphise et al. (2011) found the SNP FokI variant allele and the SNP ApaI variant 
homozygosity to be protective against vitamin D deficiency. Additionally, Ogunkolade et 
al. (2002) found the TaqI variant allele to increase insulin secretory capacity in 
Bangladeshi Asians who reside in the United Kingdom. This finding is important because 
it correlates with the function of the β-cells of the pancreas, which is associated with 
vitamin D and T2D. Why and how the differing variant homozygosity offers protection 
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only in Cuban Americans in our cohort for those with T2D is unclear at present. It may 
be that environmental factors affect the function of the VDR gene. This finding also may 
be a chance finding.  
Cuban Americans with 25(OH)D insufficiency were also older and had T2D. Age 
has been found to affect the amount of UVB waves that are emitted into the skin and the 
rate at which vitamin D is synthesized (Bischoff-Ferrari et al., 2006). Older adults are at 
particular risk of vitamin D deficiency because, as the skin ages, it cannot synthesize 
vitamin D efficiently, and the kidneys are less able to convert vitamin D to its active 
hormone form of 1,25 (OH)2D (Need, 1993). The role of vitamin D insufficiency in 
developing T2D has been studied. In Cuban Americans, we found that serum 25(OH)D 
levels were significantly lower in those with T2D compared to those without. This is in 
accordance with some, but not all, prior literature that indicates an inverse association 
between those with diabetes or at risk for diabetes and 25(OH)D levels (Grimnes, 2010; 
Kayaniyil et al., 2010; Liu et al., 2010; Scragg, Sowers, & Bell, 2004). 
African Americans who were vitamin D insufficient were females, had a higher 
BMI, were younger in age, and a greater percentage had T2D. Increased BMI may result 
in vitamin D deficiency primarily due to vitamin D being sequestered in fat cells, which 
leads to lower circulating vitamin D levels (Martini & Wood, 2006). Forrest et al. (2011) 
found that the rate of vitamin D deficiency doubled in obese adults compared to those in 
the normal BMI range. Our finding of gender difference is in agreement with that of 
Maggio et al. (2005), who showed that females had lower plasma 25(OH)D than did 
males. They hypothesized that females had decreased 25(OH)D earlier in life than did 
men and that skin thinning, which is a consequence of menopause and is age-related, is 
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responsible for lowering serum 25(OH)D levels through the action of UVB on 7-
dehydrocholesterol. Decreased intake of vitamin D sources such as milk may affect 
vitamin D levels. This is seen in African American women, who were reported to 
experience milk as having a negative taste and as being associated with intolerance 
(Zablah, Reed, Hegsted, & Keenan, 1999). Finally, we found that African Americans 
with lower 25(OH)D levels were younger. It is possible that younger African Americans 
spend more time indoors, with less exposure to sunlight, or perhaps are less likely to use 
supplements, compared to older African Americans. 
When we assessed the independent association between vitamin D levels and the 
VDR gene in both the Haitian Americans and African Americans, no association was 
noted. It is possible that TaqI and ApaI genotypes do not play an important role in these 
ethnicities or that a greater sample size for each VDR polymorphism within ethnicities 
was needed. Factors that may influence the altered vitamin D levels in Haitian Americans 
and African Americans are the degree of sun exposure, dietary intake, lifestyle factors, 
and skin color; increased skin pigmentation found in both of these groups can act as a 
natural sun block and reduce the UVB from penetrating the skin by up to 99% (Holick, 
2006). All of these factors may directly or indirectly affect vitamin D levels.  
Our findings are specific to three ethnic groups who reside in South Florida and 
cannot be generalized to these ethnic groups who live in the rest of the U.S. Additionally, 
the cause-and-effect relationship of vitamin D insufficiency and diabetes status could not 
be assessed due to the cross-sectional nature of this study. Another limitation is that skin 
color and parathyroid hormone levels were not assessed.  
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The main strength of this study was the inclusion of three ethnic groups, 
providing valuable information on vitamin D levels and VDR polymorphisms in different 
vitamin D and diabetes status. To our knowledge, the current study is the first to show 
that there is no association among ApaI, T2D, and vitamin D levels in Cuban Americans, 
Haitian Americans, or African Americans, despite having statistical power; however, 
TaqI SNP was associated with vitamin D levels in Cuban Americans.  
Further work is needed to assess vitamin D levels in different ethnic groups and 
the mechanism by which VDR polymorphisms interact with vitamin D and T2D.  Future 
studies also could explore the role in which the vitamin D binding protein and other 
vitamin D coenzymes interact with vitamin D, VDR, and diabetes status.  
In conclusion, we found an inverse association between T2D and vitamin D 
insufficiency in both Cuban Americans and African Americans. It is still unclear, 
however, which precedes the other due to the cross-sectional nature of this research. The 
evidence indicated that the TaqI variant homozygote genotype may be protective against 
vitamin D insufficiency in Cuban Americans with T2D but not in Haitian Americans or 
African Americans. This is of importance, as it highlights the protective role that VDR 
polymorphisms may play in relation to vitamin D levels, at least in some ethnicities. 
Further work is needed to explore how other potential VDR SNPs may influence or 
enhance vitamin D levels. Our findings should be confirmed through further research in 
these and other ethnicities.  
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Table 1. Characteristics of study participants by diabetes status 
 
 Participants  
 
Variables 
without T2D 
(n = 384) 
with T2D 
(n = 365) 
 
p 
Age (years) 56.1 ± 11.2 59.1 ± 11.5 <0.001 
Gender (M) (%; n) 43.5 (167) 43.8 (160) 0.94 
BMI (kg/m2)         30.0 ± 5.6         32.0 ± 6.7 <0.001 
Ethnicity (%; n)   0.23 
     Cuban Americans 38.5 (148) 32.6 (119)  
     Haitian Americans 31.0 (119) 34.5 (126)  
     African Americans 30.5 (117) 32.9 (120)  
Vitamin D intake  
(≥600 IU/d)  (%; n)     
29.9 (115)          25.5 (93) 0.17 
Serum 25(OH)D Insufficient 
(yes) (%; n) 
70.6 (271) 80.8 (295) <0.001 
BsmI   <0.001 
     BB (%; n)          13.5 (52) 6.3 (23)  
     Bb (%; n)          65.4 (251) 66.0 (241)  
     bb (%; n)          21.2 (81) 27.7 (101)  
TaqI   0.16 
     TT (%; n) 43.8 (168) 50.7 (185)  
     Tt (%; n) 47.4 (182) 41.6 (152)  
     tt (%; n)            8.9 (34) 7.7 (28)  
ApaI   0.81 
     AA (%; n) 36.0 (136) 33.9 (121)  
     Aa (%; n) 47.9 (181) 48.7 (174)  
     aa (%; n)          16.1 (61)          17.4 (62)  
 
Data are means ± SD unless otherwise indicated. p is considered significant at < 0.05. 
Abbreviations: T2D = Type 2 diabetes; BMI = body mass index; 25(OH)D = 25-hydroxyvitamin 
D. 
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Table 2. Characteristics of study participants by vitamin D receptor genotypes 
 
 TaqI   ApaI  
 TT Tt tt   AA Aa aa  
Variables (n = 253) (n = 334) (n = 62) p  (n = 256) (n = 355) (n = 123) p
Age (years) 57.6 ± 11.8 57.3 ± 11.2 58.8 ± 11.4 0.65     56.1 ± 11 58.3 ± 11.1 58.1 ± 13.3 0.54 
Gender (M) (%; n) 48.6 (159)   42.8 (28) 8.6 (140) 0.69  38.4 (123) 47.8 (153) 13.8 (44) 0.08 
BMI (kg/m2)    31.4 ± 6.8  31.2 ± 6.7  29.5 ± 5.1 0.11  31.0 ± 6.8 31.0 ± 6.7 31.9 ± 6.2 0.45 
Ethnicity (%; n)    <0.001     <0.001 
     Cuban Americans 37.8 (101) 49.8 (133)  12.4 (33)      26.8 (69) 50.2 (129) 23.0 (59)  
     Haitian Americans 52.7 (129) 40.8 (100)    6.5 (16)   8.4 (93) 51.2 (124) 10.3 (25)  
     African Americans 51.9 (123) 42.6 (101)    5.5 (13)      40.3 (95) 43.2 (102) 16.5 (39)  
With T2D (%; n) 50.7 (185) 41.6 (152)    7.7 (28) 0.16  33.9 (121) 48.7 (174) 17.4 (62) 0.81 
Vitamin D intake (≥600   
     IU/d) (%; n) 
    42.3 (88)   47.1 (98)  10.6 (22) 0.16     35.6 (72) 52.0 (105) 12.4 (25) 0.32 
Serum 25(OH)D (nmol/L) 61 ± 28  62.5 ± 26   70.1 ± 33 0.51  60.0 ± 24 63.0 ± 28  64.0 ± 34 0.26 
25(OH)D (nmol/L)     
     Insufficient 
    
0.05 
     
0.48 
     Yes (%; n) 48.4 (274) 44.7 (253)    6.9 (39)   36.0 (200) 47.9 (266) 16.0 (89)  
     No  (%; n)     43.2(79)   44.3 (81)   12.6(23)      31.7 (57)  49.4 (89) 18.9 (34)  
 
Data are means ± SD unless otherwise indicated. p is considered significant at < 0.05. Abbreviations: T2D = Type 2 diabetes; BMI = body 
mass index; 25(OH)D = 25-hydroxyvitamin D.
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Table 3. Characteristics of study participants within three ethnicities by vitamin D status 
 
 Cuban Americans   Haitian Americans   African Americans  
 Insufficient Sufficient   Insufficient Sufficient   Insufficient Sufficient  
Variables (n = 165) (n = 102) p  (n = 204) (n = 41) p  (n = 197) (n = 40) p
Age (years) 65.3 ± 11.8 60.1 ± 9.7 <0.001  55.7 ± 9.4 58.3 ± 10.0 0.16  51.9 ± 9.4 55.4 ± 9.7 0.04 
Gender (M)  
(%; n) 
30.9 (51) 42.2 (43) 0.06  47.5 (97) 43.9 (18) 0.67  6.2 (91) 67.5 (27) 0.01 
BMI (kg/m2)  31.0 ± 3.0 30.6 ± 5.3 0.39  29.3 ± 5.1 28.3 ± 5.0 0.22  34.3 ± 8.0 29.0 ± 5.9 <0.001
With T2D (%; n) 54.5 (90)   28.4 (29) <0.001  48.5 (99) 65.9 (27) 0.04  53.8 (106) 35.0 (14) 0.03 
Vitamin D intake  
(≥600 IU/d) (%; n) 
27.3 (45) 30.4 (31) 0.58  17.2 (35) 29.3 (12) 0.07   34.0 (67) 45.0 (18) 0.186 
TaqI   0.03    0.51    0.94 
     (TT) (%; n) 37.0 (61) 39.2 (40)     53.9 (110) 46.3 (19)    52.3 (103) 50.0 (20)  
     (Tt) (%; n) 54.5 (90) 42.2 (43)   39.2 (80) 48.8 (20)    42.1 (83) 45.0 (18)  
     (tt) (%; n)   8.5 (14) 18.6 (19)     6.9 (14) 4.9 (2)   5.6 (11) 5.0 (2)  
Wildtype 
homozygote 
  0.71    0.38    0.86 
     TT (%; n) 37.0 (61) 39.2 (40)     53.9 (110) 46.3 (19)   52.3 (103)   50.0 (2)  
     Tt/tt (%; n)   63.0 (104) 60.8 (62)   46.1 (94) 53.7 (22)    47.7 (94) 50.0 (20)  
Variant homozygote   0.01    0.64    0.88 
     tt (%; n)    8.5 (14) 18.6 (19)     6.9 (14) 4.9 (2)   5.6 (11) 5.0 (2)  
     TT/Tt (%; n)   91.5 (151) 81.4 (83)     93.1 (190) 95.1 (39)   94.0 (186) 95.0 (38)  
 
Data are means ± SD unless otherwise indicated. p is considered significant at < 0.05. Abbreviations: T2D = Type 2 diabetes; BMI = body 
mass index; 25(OH)D = 25-hydroxyvitamin D.
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Figure 1. Distribution of vitamin D status across TaqI and ApaI VDR gene among Cuban 
Americans with T2D (n = 119) 
 
 
   
  Serum 25(OH)D Insufficient percentages with different superscripts a,b were significantly     
  different using Holm’s modified Bonferroni method which was used to correct for multiple  
  comparisons. p is considered significant at < 0.05. 
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V. HOMA2 MODEL, VITAMIN D LEVELS, AND DIABETES STATUS 
IN THREE ETHNIC GROUPS 
Abstract 
Aim: To assess the association among diabetes status, homeostasis model assessment 2 
(HOMA2), and vitamin D status in Cuban Americans, Haitian Americans, and African 
Americans. 
Methods: The study included a total of 519 participants, 298 without type 2 diabetes 
(T2D) and 221 participants with T2D from Florida, U.S. Participants were recruited 
through mailing lists (African Americans and Cuban Americans) and community-based 
sources (Haitian Americans). Information was obtained on participants’ 
sociodemographic data, smoking history, and medication(s) used. Height and weight 
were measured using a SECA balance scale (Seca Corp., Columbia, MD, U.S.). Body 
mass index (BMI) was calculated as weight in kg/height in m2. Dietary intake was 
measured using a semi-quantitative food frequency questionnaire. Serum 25(OH)D levels 
were determined using a commercial ELISA kit from Immunodiagnostic Systems 
Limited (Scottsdale, AZ, U.S.). The homeostasis model assessment (HOMA2) was used 
to estimate insulin resistance (HOMA2-IR), insulin sensitivity (HOMA2-IS), and β-cell 
function (HOMA2-β). This study was approved by the Institutional Review Board at 
Florida International University (Approval No. 011210-10). 
Results: Using the data from the entire cohort, the results indicated that a greater 
percentage of participants who had T2D were vitamin D insufficient as compared to 
those without T2D (p < 0.001). Within the ethnic groups, distributions of the sufficient 
and insufficient vitamin D levels were significantly different (p < 0.001) by diabetes 
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status. Among participants without T2D who had sufficient vitamin D levels, Cuban 
Americans had the highest HOMA2-β, which was significantly higher than that among 
Haitian Americans and African Americans after adjusting for age, gender, and BMI (p < 
0.05). Additionally, African Americans’ HOMA2-β was lower in the vitamin D sufficient 
group than in the vitamin D insufficient group (p < 0.05).  
Conclusion: Cuban Americans without T2D and with sufficient vitamin D levels had 
significantly higher β-cell function than did vitamin D sufficient Haitian Americans and 
African Americans. The high percentage of sufficient serum vitamin D levels found in 
Cuban Americans may explain the better β-cell function in this ethnicity. These data 
suggest a role for increased vitamin D levels (through supplementation) to potentially 
improve β-cell function (Mitri, Dawson-Hughes, Hu, & Pittas, 2011). Interestingly, 
African Americans with vitamin D insufficiency also had increased β-cell function. The 
inverse associations may have occurred by chance, as the number of participants in the 
vitamin D sufficient group (n = 7) was much smaller than that of the insufficient group (n 
= 67). Further studies, using larger samples, are needed to determine whether these 
findings remain true. 
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Introduction 
 Vitamin D deficiency has been identified as a risk factor for type 2 diabetes (T2D) 
and cardiovascular disease (Chiu, 2004). While numerous studies have identified an 
inverse relationship between serum 25(OH)D and both beta cell function and insulin 
resistance (Forouhi, Luan, Cooper, Boucher, & Wareham,  2008; Nesby-O'Dell et al., 
2002; Scragg et al., 2004), few studies have assessed this association in different ethnic 
minorities who reside in the US. Between 2007 and 2009, 7.1% of Whites, 11.8% of 
Hispanics (7.6% of Cuban Americans), and 12.6% of Blacks, including African 
Americans and Haitian Americans, were diagnosed with diabetes (CDC, 2010). 
Additionally, Scragg et al. (2004) found that 82.1% of Blacks and 69.2% of Hispanics 
were vitamin D insufficient and that an inverse association between vitamin D levels and 
diabetes existed only in Whites and Mexican Americans but not in African Americans.  
 The use of the homeostatic model assessment 2 (HOMA2), based on the Oxford 
university HOMA2 calculator (www.ocdem.ox.ac.uk) (Wallace, Levy, & Matthews, 
2004), is used as a surrogate marker to estimate β-cell function (HOMA2- β), insulin 
resistance (HOMA2-IR), and insulin sensitivity (HOMA2-IS). Due to the increased 
prevalence of hypovitaminosis and T2D in certain ethnicities (CDC, 2010; Scragg et al., 
2004), there is an increased need to assess the association among vitamin D levels, T2D 
status, and HOMA2 in ethnic groups that may exhibit differing metabolic characteristics. 
Therefore, it is the aim of this paper to assess the association among diabetes status, 
HOMA2 model, and vitamin D status in Cuban Americans, African Americans, and 
Haitian Americans. 
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Methods 
Participants 
In this cross-sectional study, data were from three ethnic minority groups, with (n 
= 221) and without (n = 298) T2D, aged 35 years and older.  
 
Data Collection 
Participants were initially recruited by random selection from randomly generated 
mailing lists, purchased from Knowledge Base Marketing, Inc., Richardson, TX, U.S. 
Ten thousand letters, along with an invitation flyer in both English and Spanish, were 
mailed to Cuban Americans. Of the participants who received letters, 4% (n = 388) 
responded. Additionally, approximately 7,550 letters were mailed to African Americans 
with and without T2D. Of the participants who received letters, again 4% (n = 256) 
responded. Because we did not have a similar mailing list database for Haitian 
Americans, we recruited these participants from community-based sources (n = 259): (a) 
local diabetes educators and community health practitioners in Miami-Dade and Broward 
Counties; (b) Florida International University faculty, staff, and students; (c) several 
active adult apartment complexes; and (d) print advertisements and radio advertisements. 
When the calculated sample size for each ethnic group yielded sufficient power to detect 
significance differences between major variables, the recruitment of participants was 
discontinued.  
Interested participants were interviewed by phone, at which time the study 
purpose was explained and age, self-identified ethnicity (Cuban American, Haitian 
American, and African American), gender, self-reported T2D status (confirmed by 
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fasting plasma glucose (>126 mg/dL) and/or A1c (<6.5%), years since diagnosis, and 
initial treatment modalities (oral glucose-lowering drugs and insulin) were confirmed. 
Participants who did not qualify for the study (n = 28) were younger than 35 years old (n 
= 12), of another ethnicity (n = 5), or had a chronic disease or illness such as cancer, HIV 
infection, kidney failure, or hepatitis (n = 11), as these conditions could influence the 
main outcome of the study. This study was approved by the Institutional Review Board at 
Florida International University (Approval No. 011210-10). Written consent in English, 
Spanish, or Creole was obtained from the participants on their first visit to the laboratory. 
A total of 19 participants (Haitian Americans = 8; Cuban Americans = 7; and African 
Americans = 4) who reported not having diabetes were reclassified in the study as having 
T2D according to American Diabetes Association (ADA) standards.  These participants 
were provided with a copy of their laboratory results and referred to their physicians. 
Participants with insufficient amounts of blood serum, out-of-range coefficient of 
variance, or missing or out-of-range VDR values were excluded. A total of 519 
participants (Cuban Americans = 151; Haitian Americans = 185; African Americans = 
183) were included in the data analysis.  
 
Measures  
Participants were asked to complete standard self-administered questionnaires on 
site. For detailed questionnaires, trained interviewers were present to interview the 
participants and help them to complete the questionnaire. Data on participants’ 
sociodemographic characteristics, smoking history, and medication(s) used were 
obtained. Height and weight were measured using a SECA balance scale with a 
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stadiometer (Seca Corp., Columbia, MD, U.S.). Body mass index (BMI) was calculated 
as weight in kg/height in m2. 
 
Blood Collection 
Twenty ml of venous blood were collected from participants after an overnight 
fast (at least 8 hours) by a certified phlebotomist using standard laboratory techniques.  
Blood samples were collected in two tubes: a Vaccutainer Serum Separator Tube (SST) 
for analysis of glucose and another tube containing ethylenediamine tetra-acetic acid 
(EDTA) for analysis of glycosylated hemoglobin (A1c). After complete coagulation (30-
45 minutes), the SST sample was centrifuged at 2,500 RPM for 30 minutes. The serum 
was transferred into a labeled plastic tube and stored at -70°C until used. 
 
Determination of glucose and vitamin D levels and insulin 
Glucose levels were measured by hexokinase enzymatic methods. A1c 
percentages were measured from whole blood samples with the Roche Tina Quant 
method by Laboratory Corporation of America (LabCorp, Miami, FL, U.S.). Serum 
25(OH)D levels were determined using a commercial ELISA kit from Immunodiagnostic 
Systems Limited (Scottsdale, AZ, U.S.). The manufacturer’s protocol was followed to 
perform this competitive assay, according to which the standards and samples were 
diluted with biotin-labeled 25(OH)D. For this study, the interassay coefficient of 
variation (CV) for ELISA was accepted at less than 10.3% (Bodnar et al., 2007). The 
cutoff point used to determine insufficient serum 25(OH)D levels was <75 nmol/L (IOM, 
2011). Serum insulin levels were determined using the Human Insulin ELISA kit from 
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Millipore (St Charles, MZ, U.S.). The manufacturer’s protocol was followed to perform 
this Sandwich ELISA assay.  
 
Determination of beta cell function (HOMA2-β), insulin resistance (HOMA2-IR), 
and insulin sensitivity (HOMA2-IS) 
HOMA2 is based on the Oxford University HOMA2 calculator 
(www.ocdem.ox.ac.uk) (Wallace, Levy, & Matthews, 2004) and is used to estimate beta 
cell function (HOMA2-β), insulin resistance (HOMA2-IR), and insulin sensitivity 
(HOMA2-IS). The HOMA2 computer model accounts for variations in hepatic and 
peripheral glucose resistance (Rudenski, Matthews, Levy, & Turner, 1991). The 
computer model can be used to determine β-cell function (%B) insulin sensitivity (%S), 
and the insulin resistance index from paired fasting plasma glucose and 
radioimmunoassay insulin across a range of 1-2,200 pmol/l for insulin, and 1-25 mmol/l 
for glucose (Wallace et al., 2004). 
 
Data Analysis 
All statistical analyses were performed using SPSS (Version 18.0, Chicago, IL, 
U.S.). HOMA2-IS and HOMA2-IR were log transformed to achieve normality. 
Differences in mean values by ethnicity, diabetes status, and vitamin D status were 
assessed using the Student’s t-test and analysis of variance (ANOVA) for numerical 
values and χ2 test for categorical variables and analysis of covariance (ANCOVA). This 
was followed by Fisher’s least significant difference (LSD) post-hoc test, which was used 
to compare mean HOMA2 variables across diabetes status, vitamin D levels, and 
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ethnicity controlling for age, gender, and BMI. The significance level for all analyses was 
set at p < 0.05.  
 
Results 
The study included a total of 519 participants, 298 without and 221 with T2D. 
Table 1 presents the characteristics of study participants with and without T2D. 
Participants with T2D had a greater percentage of vitamin D insufficiency (83.7%) than 
those without T2D (67.1%) (p < 0.001).  
Table 2 presents the characteristics of study participants by diabetes status further 
categorized into vitamin D insufficient and sufficient. Ethnicity distribution was 
significantly different between vitamin D sufficient and insufficient participants with and 
without T2D, with Cuban Americans having a higher percentage of 25(OH)D sufficient 
participants than did Haitian American or African American participants in both diabetes 
statuses (p < 0.01).  
Table 3 presents the characteristics of study participants by diabetes status further 
categorized by ethnic groups. Participants with T2D and without T2D (wT2D) were 
analyzed separately. Participants with and without diabetes are not comparable because 
participants with T2D exhibit different pancreatic functions and altered metabolic 
functions. The findings showed that Cuban Americans were older than Haitian 
Americans and African Americans (wT2D, T2D), p < 0.05. Cuban Americans, compared 
to Haitian Americans and African Americans, also had significantly higher means of 
insulin secretion, HOMA2-β, and log HOMA2-IR (wT2D, T2D), p < 0.05. However, 
Haitian Americans had a significantly higher log HOMA2-IS compared to Cuban 
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Americans (wT2D, T2D), p < 0.05, and African Americans (wT2D, T2D), p < 0.05, with 
the lowest HOMA2-β compared to Cuban Americans, and African Americans (wT2D, 
T2D), p < 0.05. African Americans were significantly younger than Cuban Americans 
and Haitian Americans (wT2D, T2D) and had the highest BMI compared to Cuban 
Americans and Haitian Americans (wT2D, T2D), p < 0.05. 
Table 4 presents the HOMA2- β interaction results between vitamin D status and 
ethnicity within diabetes status after adjusting for age, gender, and BMI. Interaction 
between ethnicity and vitamin D level was statistically significant, F(2, 289) = 3.27, p = 
0.040, for participants without T2D. Among participants without T2D who had sufficient 
vitamin D levels, Cuban Americans had the highest HOMA2-β (M = 115.1), which was 
significantly higher than that for Haitian Americans (M = 86.2) and African Americans 
(M = 90.4), p < 0.05. For African Americans without T2D, there was a significant 
difference between vitamin D insufficient and sufficient groups (p < 0.05). African 
Americans with vitamin D insufficiency (M = 106.9) had increased HOMA2-β compared 
to those with vitamin D sufficiency (M = 90.4). 
 
Discussion 
We have demonstrated that Cuban Americans without T2D and with sufficient 
vitamin D levels had significantly higher β-cell function than did vitamin D sufficient 
Haitian Americans and African Americans without T2D. The high percentage of 
sufficient serum vitamin D levels found in Cuban Americans may explain the higher β-
cell function, which suggests the potential role of increased vitamin D levels (through 
supplementation) in improving β-cell function (Mitri, Dawson-Hughes, Hu, & Pittas, 
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2011) and where vitamin D is thought to play a direct role on β-cell function (Eliades & 
Pittas, 2009). The increased levels of vitamin D in Cuban Americans may be a result of 
greater sun exposure, whereby lighter Caucasian skin pigmentation absorbs 24% of UVB 
rays compared to Black epidermis, which absorbs 7.4% of UVB (Gloster & Neal, 2006). 
Altered vitamin D levels also may be associated with genetic factors. Additionally, 
Cuban Americans without T2D showed increased insulin secretion and higher log 
HOMA2-IR than did African Americans and Haitian Americans without T2D. The 
increased log HOMA2-IR in Cuban Americans may be associated with factors such as 
physical inactivity and an increased BMI (Amati et al, 2009) or being of a specific 
ethnicity (Haffner et al., 1996). 
African Americans without T2D showed a significant difference in β-cell function 
between participants with and without vitamin D insufficiency, whereby those with 
vitamin D insufficiency had increased β-cell function. Our findings conflict with those of 
Chiu, Chu, Liang, Go, and Saad (2004), who found that low levels of vitamin D had a 
negative effect on β-cell function. They did not, however, have an African American 
sample as part of their study group. The inverse associations found between vitamin D 
levels and β-cell function in African Americans may have occurred by chance, as the 
number of participants in the vitamin D sufficient group (n = 7) were much smaller than 
the insufficient group (n = 67). Further studies, using larger samples, are needed to assess 
whether these findings remain true. 
Among the three ethnicities, Cuban Americans and African Americans had higher 
BMI (>30), β-cell function, log HOMA2-IR, and insulin secretion, with lowest log 
HOMA2-IS, compared to Haitian Americans. Research has shown that participants 
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without T2D and with a BMI  > 30 are characterized by extra-hepatic insulin resistance, 
as in seen in Cuban American and African American participants (Felber, 1992; Paquot, 
2002). It is important to note that no statistically significant association was seen between 
β-cell function and BMI in our study. Thus, to draw further conclusions, additional 
studies should be conducted. Cuban Americans and African Americans also showed an 
overall decline of HOMA2- β and log HOMA2- IS for those with T2D. This decline 
demonstrates the nature of T2D, an exhaustion of the β-cells of the pancreas due to 
chronic insulin resistance (Buchanan, 2002). 
The heightened insulin sensitivity in Haitian Americans may be indicative of the 
role that a lower BMI (<30) may play, whereby a lower BMI increases insulin sensitivity, 
which leads to lowered insulin secretion and insulin resistance (Ahre ́n & Pacini, 2005; 
Mari, Ahre ń, & Pacini, 2005). The exact mechanism in Haitian Americans who have 
heightened insulin sensitivity is still unclear. A high percentage of Haitian Americans 
also had low vitamin D levels; however, these low levels did not play a significant role in 
log HOMA2-IS, HOMA2- β or log HOMA2- IR. Low circulating levels of 25(OH)D in 
the majority of Haitian Americans may account for why there was no association was 
found between vitamin D and the HOMA2 model. It is suspected that low 25(OH)D is 
primarily due to Haitian Americans’ higher skin pigmentation, which causes darker skin 
color that limits the amount of ultraviolet light that can penetrate, thereby reducing 
cutaneous synthesis of vitamin D3 (Aloia, 2008). Although Haitian Americans presented 
unique findings compared to their counterparts, no statistically significant differences 
were found. This likely is explained by the small percentage of vitamin D sufficient 
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participants, which decreased the possibility of significant findings. Genetic and other 
lifestyle factors also underlie the unique findings in Haitian Americans. 
The limitations of this study were that skin color was not measured and reverse 
causation could not be assessed with regard to HOMA2 findings and vitamin D levels. 
Additionally, β-cell function, among other factors, was calculated using HOMA2, an 
indirect method of measurement of β-cell function. Another limitation is that few studies 
exist on the three ethnicities, and, thus, few conclusions and comparisons could be made.  
The strengths of the study include its assessment of vitamin D levels with regard 
to HOMA2 model in three distinct ethnic groups that have been understudied. 
Additionally, the separation of two Black ethnicities was important, allowing ethnic 
differences to be identified between African American and Haitian Americans. 
In conclusion, participants with and without T2D showed differences due to 
ethnicity with regard to HOMA2, vitamin D, and general characteristics. These findings 
indicate that all three ethnicities should be assessed as individual ethnic groups when 
considering the HOMA2 model. We also can assume that, due to the diverse background 
of participants in each ethnic group, each presents unique metabolic functions, genetics, 
diets, and lifestyle factors that may ultimately affect vitamin D levels and progression of 
T2D. Further investigation is warranted to assess how β-cell function, insulin sensitivity, 
and insulin resistance may alter in the presence and absence of vitamin D in differing 
ethnicities.  
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Table 1. Characteristics of study participants by diabetes status 
 
 Participants  
 
Variables 
without T2D 
(n = 298) 
with T2D 
(n = 221) 
 
p
Age (years)                       54.4 ± 10.6 60.6 ± 11.7 <0.001 
Gender (F) (%) 53.7 (160) 59.7 (132) 0.170 
BMI (kg/m2)                       30.1 ± 5.6                    32.5 ± 7.2 <0.001 
Ethnicity (%)   0.068 
     Cuban American                        25.2 ( 75)                     34.4 (76)  
     Haitian American 38.3 (114)                     32.1 (71)  
     African American 36.6 (109)                     33.5 (74)  
FPG                       97.8 ± 15.0                  141.0 ± 53.4 <0.001 
Insulin                       11.2 ± 6.9                    13.3 ± 9.4 0.006 
HOMA2-β                     103.2 ± 37.5                    70.0 ± 42.3 <0.001 
HOMA2-IS                       92.1 ± 50.5 79.3 ± 49.2 0.004 
Log HOMA2-IS                         4.4 ± 0.6 4.2 ± 0.6 <0.001 
HOMA2-IR                         1.5 ± 0.9 1.8 ± 1.4 <0.001 
Log HOMA2-IR 0.2 ± 0.6 0.4 ± 0.6 <0.001 
25(OH)D (nmol/L)  Insufficient (Yes) (%)  67.1 (200)                     83.7 (185) <0.001 
 
Data are means ± SD unless otherwise indicated. p is considered significant at < 0.05. Abbreviations: T2D = Type 2 diabetes; BMI = body 
mass index; HOMA2-β = homeostasis model assessment of β-cell function; IR = Insulin resistance; FPG = fasting plasma glucose; 25(OH)D = 
25-hydroxyvitamin D. Serum 25-hydroxyvitamin D insufficiency (<75 nmol/L). 
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Table 2. Characteristics of study participants without and with type 2 diabetes by vitamin D status  
 
 Participants   
 without T2D  with T2D  
25(OH)D   25(OH)D  
 
Variables 
Insufficient 
(n = 200) 
Sufficient 
(n = 98) 
 
p 
 Insufficient 
(n = 185) 
Sufficient 
(n = 36) 
 
p 
Age (years) 52.9 ± 10.5     57.3 ± 10.4 0.67      60.2 ± 12.2 62.8 ± 9.1 0. 69 
Gender (F) (%; n) 55.0 (110)       51.0 (50) 0.52  60.5 (112) 55.6 (20) 0.58 
BMI (kg/m2)       30.4 ± 5.8     29.4 ± 4.9 0.13      32.6 ± 7.4 30.9 ± 6.1 0.19 
Ethnicity (%; n)   <0.001    <0.05 
     Cuban American 8.0 (16) 60.2 (59)        30.3 (56) 55.6 (20)   
     Haitian American 50.5 (101) 13.3 (13)        33.5 (62)      25.0 (9)  
     African American        41.5 (83) 26.5 (26)        36.2 (67)      19.4 (7)  
FPG 98.1 ± 15.8     97.4 ± 11.7 0.70    138.7 ± 53.6 154.8 ± 51.0 0.10 
Insulin       11.3 ± 7.1     11.3 ± 6.7 0.99      13.0 ± 9.4 14.5 ± 9.1 0.40 
HOMA2-β     103.4 ± 39.2   102.8 ± 34.0 0.92      72.5 ± 43.6   61.7 ± 33.8 0.16 
HOMA2-IS 92.8 ± 51.4     90.7 ± 49.0 0.74      82.2 ± 50.8   64.5 ± 37.1 0.01 
Log HOMA2-IS   4.4 ± 0.57       4.4 ± 0.6 0.86      54.2 ± 0.7   4.0 ± 0.6 0.11 
HOMA2-IR   1.5 ± 0.94       1.5 ± 0.9 0.99        1.9 ± 1.4   2.1 ± 1.3 0.56 
Log HOMA2-IR   0.2 ± 0.57       0.2 ± 0.6 0.85  0.4 ± 0.7   0.6 ± 0.6 0.10 
 
Data are means ± SD unless otherwise indicated. p is considered significant at < 0.05. Abbreviations: T2D = Type 2 diabetes; BMI = body 
mass index; HOMA2-β = homeostasis model assessment of β-cell function; IR = Insulin resistance; FPG = fasting plasma glucose; 25(OH)D = 
25-hydroxyvitamin D. Serum 25-hydroxyvitamin D insufficiency <75 nmol/L. 
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Table 3. Characteristics of study participants without and with type 2 diabetes by ethnicity 
 
 Participants  
  without T2D   (n = 298)     with T2D   (n = 221)  
 
 
Variables 
Cuban 
Americans 
(n = 75) 
Haitian 
Americans 
(n = 114) 
African 
Americans 
(n = 109) 
 
 
p 
 Cuban 
Americans 
(n = 76) 
Haitian 
Americans 
(n = 71) 
African 
Americans 
(n = 74) 
 
 
p 
Age (years)   60.0 ± 10.7a 54.1 ± 10.9b  50.9 ± 8.5c <0.001  67.1 ± 11.4a 58.6 ± 10.0b 55.9 ± 10.7c <0.001 
Gender (F) (%; n) 61.3 (46) 51.8 (59) 50.5 (55)   0.302     65.8 (50) 57.7 (41)    55.4 (41)   0.396 
BMI (kg/m2)   30.1 ± 4.2ab  28.8 ± 5.0b  31.3 ± 6.6a   0.003    32.6 ± 7.2b   29.2 ± 4.5c 35.2 ± 8.1a <0.001 
FPG 97.1 ± 13.2  99.6 ± 16.7 96.4 ± 12.9   0.233  146 ± 54.5 145.0 ± 51.6  133 ± 53.5   0.261 
Insulin   12.5 ± 6.8a  10.0 ± 5.5c  11.7 ± 8.2b   0.033  17.4 ± 10.8a 9.9 ± 7.8c 12.2 ± 7.4b <0.001 
HOMA2-β 111.7 ± 33.1a  94.9 ± 38.7b   106 ±37.5ab   0.006  80.0 ± 44.7a 56.4 ± 37.1c 74.9 ± 41.2b   0.002 
HOMA2-IS  80.2 ± 44.2b  99.6 ± 51.4a 92.4 ±52.5b   0.034  60.1 ± 46.1b 98.9 ± 51.4a 80.2 ± 42.7c <0.001 
Log HOMA2-IS  4.2 ± 0.5b    4.5 ± 0.5a   4.4 ± 0.6ab   0.027  3.9 ± 0.6b 4.4 ± 0.6a   4.2 ± 0.6c <0.001 
HOMA2-IR 1.7 ± 0.9a 1.3 ± 0.7b   1.6 ± 1.1ab   0.041  2.5 ± 1.5a 1.4 ± 1.1b   1.7 ± 1.1b <0.001 
Log HOMA2-IR 0.4 ± 0.5a 0.1 ± 0.5b   0.2 ± 0.6ab   0.029  0.7 ± 0.6a 0.2 ± 0.6c   0.4 ± 0.6b <0.001 
25(OH)D 
Insufficient  
(Yes) (%; n) 
21.3 (16)   88.6 (101) 76.1 (83)  <0.001     73.7 (56) 87.3 (62) 90.5 (67)   0.012 
 
Data are means ± SD unless otherwise indicated. p is considered significant at < 0.05. Abbreviations: T2D = Type 2 diabetes; BMI = body 
mass index; HOMA2-β = homeostasis model assessment of β-cell function; HOMA2-IS = homeostasis model assessment of insulin 
sensitivity; HOMA2-IR = homeostasis model assessment of insulin resistance; FPG = fasting plasma glucose; 25(OH)D = 25-hydroxyvitamin 
D. Serum 25- hydroxyvitamin D insufficiency (<75 nmol/L). Ethnic groups with different superscripts are significantly different from each 
other. Fisher’s least significant difference (LSD) test was used to correct for multiple comparisons. 
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Table 4. HOMA2- β means by vitamin D status and ethnicity within diabetes status 
 
              Variable 25(OH)D Cuban American Haitian American African American 
Without T2D Insufficient  (<75 nmol/L) 100.9 ± 8.8              99.1 ± 3.5 106.9 ± 4.0 
Sufficient     (≥75 nmol/L)  115.1 ± 4.6a  86.2 ± 9.6b    90.4 ± 6.8b 
     
With T2D Insufficient  (<75 nmol/L)   82.7 ± 5.9              57.1 ± 5.4   78.0 ± 5.3 
Sufficient     (≥75 nmol/L)   65.3 ± 9.1   61.7 ± 13.7     53.1 ± 15.5 
 
Interaction between ethnicity and vitamin D was statistically significant F (2, 289) = 3.27, p = 0.040. Data are means ± SD unless otherwise 
indicated. Control variables included were: age, gender, BMI. p is considered significant at p < 0.05. Ethnic groups with different superscripts 
in a row are significantly different from each other. Fisher’s least significant difference (LSD) test was used to correct for multiple 
comparisons. Abbreviations: T2D = Type 2 diabetes
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VI.  SUMMARY AND DISCUSSION 
This dissertation examined the association of vitamin D levels, VDR 
polymorphisms and HOMA2 model in Cuban Americans, Haitian Americans, and 
African Americans with and without T2D.  
We found that for all ethnicities combined that vitamin D insufficiency was 
greater in participants with T2D than without after controlling for all relevant variables. 
The mechanism of action of vitamin D in diabetes is not completely understood in 
humans; however, it is thought that vitamin D deficiency impairs insulin synthesis and 
secretion in β- cells of the pancreas, resulting in the development of T2D (Gerich, 2003). 
There were significant differences in vitamin D levels across ethnic groups and diabetes 
status with Cuban Americans having the highest vitamin D levels compared to Haitian 
Americans, and African Americans. Scragg et al.(2004) used the Third National Health 
and Nutrition Examination Survey and found ethnic variations in 25(OH)D levels. Whites 
had the highest 25(OH)D concentrations followed by Mexican Americans and lowest in 
Blacks (Scragg et al., 2004). These results are in agreement with our study. The most 
likely explanation of the vitamin D difference found, may be partially explained by the 
variation in the skin color by ethnicity. Where, Cuban Americans had predominantly 
lighter skin color which may have allowed them greater UVB exposure than Haitian 
Americans, and African Americans. Our hypothesis that Cuban American, Haitian 
American, and African American participants combined, with T2D will have lower 
serum vitamin D levels than their counterparts without T2D is based on research of 
Baynes et al.(1997) and was found to be highly significant. However, upon stratification 
of ethnicities, this finding was only significant in Cuban Americans. Haitian Americans 
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without T2D showed greatest risk of 25(OH)D insufficiency when compared to Cuban 
Americans without T2D. Factors such as skin pigmentation, genetic or lifestyle factors 
may have contributed to the Haitian American findings. 
Our study supports the hypothesis that Haitian American, and African American 
participants will have lower serum vitamin D levels as compared to Cuban American, in 
particular, Cuban Americans without T2D. Our findings did not support the hypothesis 
that the Cuban Americans, Haitian Americans, and African Americans with adequate 
(>400 IU/day) vitamin D intake will have ‘sufficient’ (≥ 75nmol/L) serum vitamin D 
levels regardless of diabetes status. We found that African Americans had the highest 
vitamin D intake (~ 449 IU/day) based upon 400IU/day, which was the old criterion for 
recommended dietary allowance of vitamin D. However, this intake did not translate into 
sufficient serum vitamin D levels in this population group. In 2010 the Institute of 
Medicine (IOM) defined recommended dietary allowance of vitamin D as 600 IU/day for 
those between the ages of 1-70 (including pregnancy and lactation), and 800 IU/day in 
those over 70 (IOM, 2010). Regardless of the altered intake criteria, analysis of this 
population group still would have an average intake of ~ 449 IU/day in African 
Americans, which would be below the newly recommended 600 IU/day from the IOM 
but still not at a ‘sufficient’ level in order to support our hypothesis. 
When we assessed the relationship among serum 25(OH)D levels, VDR 
polymorphisms (BsmI, TaqI and ApaI), and diabetes status in the three ethnic groups 
(Cuban Americans, Haitian Americans, and African Americans) residing in South 
Florida, we found that BsmI (rs1544410) genotype distribution showed a departure from 
the Hardy-Weinberg equilibrium (HWE) due to the low frequency of the wildtype 
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homozygote genotype and an excess of heterozygosity in groups with and without T2D. 
BsmI was excluded from the study on the basis that results on the agarose gel and in 
TaqMan allelic discrimination assay by real-time PCR were inconsistent and unclear. 
Before we ruled out BsmI, a number of tests were run in order to identify the nature of the 
deviation from HWE. Firstly, to rule out misclassification of samples (1) gel bands were 
re-examined by a second researcher with no knowledge of prior interpretation of the 
bands and diabetes status of samples. To rule out partial digestion of samples, running 
real time PCR on 5% of randomly selected control samples of each genotype (BB, Bb, 
and bb) was conducted and compared to TaqMan results. Genotyping results remained 
ambiguous and indicated a greater heterozygosity rate in PCR-RFLP. It was therefore 
concluded that either an unknown polymorphism around the SNP or a paralogous gene 
sequence in the genome interfered with the genotyping of rs1544410. In addition, upon 
further analysis, we found that BsmI and TaqI polymorphisms are in strong linkage 
disequilibrium. Polymorphisms that are in linkage disequilibrium have the same 
predictive value for the association with the phenotype (Ersoz, Yu, & Buckler, 2009). 
This means that association results for locus BsmI (rs1544410) and TaqI (rs7321236) 
would have been similar. Therefore, only one polymorphism needed to be studied, and 
thus BsmI was safely removed and TaqI assumed its place (a detailed account is 
presented in Appendix I). 
We found an association between TaqI and ApaI genotypes among ethnicities (p < 
0.001). Cuban Americans were 7.3 times more likely to be vitamin D insufficient if they 
had the recessive trait TaqI TT and Tt, 95% CI (1.97 to 26.9). This partially supports the 
hypothesis that there will be a higher prevalence of polymorphisms in the VDR gene 
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restriction sites BsmI, ApaI and TaqI for participants with diabetes as compared to 
participants without diabetes for all ethnicities. As an association between TaqI and 
vitamin D was only found in Cuban Americans with T2D. No association was found in 
ApaI, ethnicity and vitamin D levels. We also found no association between differences 
in the prevalence and types of VDR polymorphisms among the three ethnicities in both 
participants with and without T2D. This may be due to the small sample size within each 
ethnicity and where each VDR polymorphism was further divided into three genotypes. 
 A number of hypotheses were not proven as no association was found between 
HOMA2 modules and VDR polymorphism in each ethnicity, this again is believed to be 
due to the small sample size for VDR polymorphisms. Further work is needed to assess 
vitamin D levels in different ethnic groups and the mechanism in which VDR 
polymorphisms interact with vitamin D and T2D.  
 Finally, we assessed the association among diabetes status, HOMA2 model and 
vitamin D status in Cuban Americans, Haitian Americans, and African Americans. Cuban 
Americans had the highest HOMA2-β which was statistically different from both Haitian 
Americans and African Americans. Additionally, African Americans HOMA2-β was 
lower in the vitamin D sufficient group compared to the vitamin D insufficient group. We 
found no significant association between HOMA2-IR and vitamin D levels in for any of 
the ethnicities, which disproves the hypothesis that an association would be found. 
 We can conclude that of the three ethnicities, Cuban Americans had the highest 
vitamin D levels, a protective factor in SNP TaqI (tt) for Cuban Americans with T2D, 
and the highest β-cell function compared to the African Americans and Haitian 
Americans.  
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VII.  STRENGTHS AND LIMITATIONS 
Our study had some significant strengths; firstly it included three different ethnic 
groups, providing valuable information regarding vitamin D levels, VDR polymorphisms 
and HOMA2 model in different ethnicities and diabetes status with few other studies 
focusing on these ethnicities. This study is the first to consider differences in two Black 
American ethnicities with regards to VDR polymorphisms and HOMA2 model.  
There were several limitations of this study; we could not determine cause and 
affect due to the observational and cross sectional nature of the study. The samples of 
Cuban Americans, Haitian Americans, and African Americans may not be representative 
of the same ethnicities residing in other parts of Florida or the U.S. Skin color, 
parathyroid hormone levels and vitamin D binding protein were not assessed in order to 
better understand vitamin D status. Additionally, the proportion of subjects that were 
vitamin D sufficient was small in the Haitian Americans, and African Americans, which 
may have influenced our results. HOMA2 model was used as a surrogate/indirect marker 
for insulin sensitivity, resistance and β-cell function; other direct measures could have 
been used such as C-peptide measurement for β-cell function and euglycaemic insulin 
clamp for insulin resistance which has been considered the gold standard (Ferrannini & 
Mari, 1998).  
Findings suggest further research is needed to assess vitamin D levels in different 
ethnic groups, with emphasis on β-cell function, insulin secretion and insulin resistance. 
Additionally, the mechanism in which VDR polymorphisms interact with vitamin D and 
T2D is necessary to further understand the complexity that ethnicity combined with 
chronic disease may present. 
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VIII.  FUTURE RESEARCH 
Our findings indicate a strong need to recognize each ethnicity as individual 
populations with special attention to the differences within Black populations. A greater 
understanding is needed with regards to the role of vitamin D in the metabolism of 
glucose, insulin production, and regulation of β-cell function. Cuban Americans, Haitian 
Americans and African Americans should also be further investigated to have a better 
understanding of the role of Vitamin D, VDR polymorphisms and HOMA2 model. 
Awareness of the high prevalence of vitamin D insufficiency among African Americans 
and Haitian Americans and also in those with T2D may prompt awareness among 
physicians and dietitians with intent to prevent vitamin D insufficiency.  
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APPENDIX  
Table 1. Vitamin D receptor genotype (BsmI) by diabetes status.  
 
 Participants  Participants 
Variables without T2D (%) p value  with T2D (%) p value 
BsmI      
Cuban American  <0.05   <0.05 
     BB 20.3   5.9  
     Bb 65.5             89.1  
     bb 14.2   5.0  
African American  <0.05   0.1 
     BB   6.0   8.3  
     Bb 77.8             51.7  
     bb 16.2             40.0  
Haitian American  0.2    0.05 
     BB 12.6   4.8  
     Bb 52.9             57.9  
     bb 34.5             37.3  
 
Abbreviations: T2D = Type 2 diabetes. p is considered significant at < 0.05. 
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Figure 1. Linkage disequilibrium of BsmI, TaqI and ApaI 
 
 
 
 
All three SNPs are highly correlated with one another in Caucasians. Especially, 
rs731236 (TaqI) and rs1544410 (BsmI) are in strongest correlation (D’ 1.0 out of 1.0; 
LOD score = 112 (significance threshold is 3.0); R2 = 0.96 out of 1.0 and significance 
threshold for high correlation is 0.80). This indicates that there is no need to repeat both 
SNPs (rs731236 and rs1544410) since one of them is providing the same information as 
the other. 
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